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PROFILING EQUINE ENDOMETRIAL GENE EXPRESSION DURING MATERNAL 
RECOGNITION OF PREGNANCY  
 
 In order to maintain a pregnancy in the mare the presence of a conceptus in the uterus 
must be recognized by the endometrium. This is known as maternal recognition of pregnancy 
(MRP) and is required to prevent the secretion of prostaglandin F2α (PGF), starting on day 14 
post-ovulation, from the endometrium into circulation. The secretion of PGF initiates luteolysis 
of the corpus luteum, which is secreting progesterone, the hormone needed to maintain a 
pregnancy. However, little is known about maternal recognition of pregnancy in the mare. It is 
critical that the embryo is mobile throughout the entire uterine lumen to signal maternal 
recognition of pregnancy between days 12-14. The embryo ceases mobility on day 16 by fixing 
at the base of one of the uterine horns, independent of the side of ovulation. Previously, an 
equine specific microarray analysis was performed on days 14, 16, and 18 post-ovulation 
comparing endometrial gene expression between pregnant and non-pregnant mares. From this 
analysis, ten genes: juxtaposed with another zinc finger protein 1-like (JAZF1), secretory 
phospholipase A2 (sPLA2), S100 calcium binding protein G (S100G), estrogen receptor 1 
(ESR1), solute carrier family 36 (proton/amino acid symporter), member 2 (SLC36A2), 
methyltransferase-like protein 7A-like (METTL7A), retinaldehyde dehydrogenase 1-like 
(RALDH1), eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3), dickkopf 1 
homolog (DKK1), and adrenomedullin (ADM), were identified as having consistently higher or 
lower expression levels in the endometrium of pregnant mares at all three time points. The goal 
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of this study was to confirm and expand upon the results of the microarray on days 14, 16, and 
18, by real time PCR (RT-PCR), and to evaluate differential gene expression on day 12. We 
hypothesized that the expression of the aforementioned ten genes will be the same on day 12 
endometrium from pregnant mares as days 14, 16, and 18 endometrium from pregnant mares 
because day 12 is the start of maternal recognition of pregnancy.  
To test this hypothesis, 12 normally cycling mares were utilized in a crossover design. 
Each mare was assigned to a random collection day (day 12, 14, 16, or 18 post-ovulation) and 
provided endometrial samples from a pregnant cycle and then a non-pregnant (non-mated) cycle 
(n=3 per day). Endometrial biopsy samples were snap frozen and stored until total RNA was 
isolated for RT-PCR. This analysis was consistent with the microarray results for days 14, 16, 
and 18. On day 12, 6 of the 10 differentially expressed genes had the same pattern of expression 
as day 14, but 4 of the genes had opposite expression levels on day 12. 
 Endometrial samples were then collected on day 13 post-ovulation (n=3) and processed 
for protein isolation and immunohistochemical analysis. The specificity of rabbit polyclonal 
antibodies for sPLA2 and DKK1 for equine endometrium were confirmed by Western Blot 
analysis. Upon conformation of antibody specificity, immunohistochemistry was used to 
determine the localization of sPLA2, DKK1, and ESR1. sPLA2 was localized to the endometrial 
epithelium and glandular epithelium in the endometrium from both pregnant and non-pregnant 
mares. DKK1 showed a localization difference between endometrial samples from pregnant and 
non-pregnant mares. In the endometrium from the pregnant mare, DKK1 was localized to the 
endometrial epithelium and the glandular cells, and in the endometrium from the non-pregnant 
mare DKK1 was localized throughout the glandular region, but not in the endometrial epithelium. 
ESR1 also showed differential localization based upon pregnancy status. In the endometrium 
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from the pregnant mare, ESR1 was located in the basal glandular region and not close to the 
lumen or in the endometrial epithelium. In endometrium from non-pregnant mares it was located 
throughout the entire glandular region and in the endometrial epithelium.  
 This experiment identified the expression patterns of ten genes, previously identified 
from a microarray analysis, on days 12, 14, 16, and 18 post-ovulation in the endometrium from 
pregnant and non-pregnant mares. The expression patterns on days 14, 16, and 18 were 
consistent across each day. Day 12 revealed mixed results for the expression patterns of these 
genes, indicating that they were undergoing transcriptional regulation based upon the presence or 
absence of a mobile conceptus. By determining what signal causes these genes to be higher or 
lower expressed in the endometrium of pregnant mares, it may lead to the identity of the signal 





If you would have asked me two years if I would go to graduate school my answer would 
have been a definite no. I have many people to thank for being here today. First of all, I would 
like to thank Dr. Burt Staniar, my undergraduate advisor from Penn State University. Thank you 
for putting the little bug in my ear that I should maybe try graduate school. Had it not been for 
you, graduate school would not have been an option for me. Your confidence in me during my 
undergraduate and telling me to pursue something more helped to build my own confidence and 
bring me here today. I owe this step in my life to you.  
To Denny and Gina Hoffman, whom are some of the best horsemen I know, thank you 
for taking a chance on an 18 year old that just wanted to work around horses. Working with you 
instilled my passion for reproduction and led me to want to do more for the equine reproduction 
industry.  
To Elena Ruggeri, your friendship and support through these two years has been priceless. 
From helping me keep my sanity when I had to spend long, countless hours working in the lab to 
being my moral support for when I was doubting things, I thank you. You have helped me so 
much through this process.   
To my committee members Drs. Bruemmer, Bouma, and Thomas, thank you for your 
guidance through this process. Also thank you for being patient with me as I would come up with 
a thousand random questions regarding anything and everything.  
To Dr. Bruemmer, who originally agreed to meet with me for ice cream at Berkey 
Creamery on a quick trip day trip to Penn State. Thank you for giving me the opportunity to 
teach, lead, and research. Your guidance has lead me in the direction of academia and showed 
! vi!
me what I truly wanted to pursue in a career. You have taught me the importance of research, 
integrity, horsemanship, and personal skills when researching in general and in the equine 
industry.  
Finally, to my parents Joy and Mark I owe a huge thank you. Your never-ending support 
through this process is invaluable. You have allowed to me to experience anything I have ever 
wanted and never doubted any of my decisions. When I said I was moving to Colorado to pursue 
a Master’s degree you never questioned by choice and showed nothing but support for me. You 
have always encouraged me through everything and for that I can never thank you enough.   
! vii!
TABLE OF CONTENTS 
 
 
ABSTRACT ................................................................................................................................... ii 
ACKNOWLEDGEMENTS ............................................................................................................ v 
LIST OF TABLES ......................................................................................................................... ix 
LIST OF FIGURES ......................................................................................................................... x 
LIST OF APPENDICES ................................................................................................................ xi 
CHAPTER I: REVIEW OF LITERATURE ................................................................................... 1 
INTRODUCTION ............................................................................................................................. 1 
EQUINE ESTROUS CYCLE .............................................................................................................. 1 
EARLY PREGNANCY IN THE MARE ................................................................................................ 3 
MATERNAL RECOGNITION OF PREGNANCY IN OTHER SPECIES ..................................................... 6 
MATERNAL RECOGNITION OF PREGNANCY IN THE MARE ............................................................. 9 
EARLY EMBRYONIC LOSS ........................................................................................................... 12 
CONCLUSION .............................................................................................................................. 13 
CHAPTER II: PROFILING GENE EXPRESSION IN EQUINE ENDOMETRIUM DURING 
MATERNAL RECOGNITION OF PREGNANCY (DAYS 12, 13, 14, 16, AND 18) ................ 14 
SUMMARY .................................................................................................................................. 14 
INTRODUCTION ........................................................................................................................... 15 
MATERIALS AND METHODS ........................................................................................................ 15 
Horse Care ............................................................................................................................ 15 
Experimental Design ............................................................................................................. 16 
Endometrial Biopsy Collection for Days 12, 14, 16, and 18 ................................................. 16 
Endometrial Biopsy Collection for Day 13 ........................................................................... 17 
RNA Isolation and Quantification ......................................................................................... 18 
Protein Isolation and Quantification ..................................................................................... 18 
Reverse Transcription ........................................................................................................... 19 
Sequencing ............................................................................................................................. 19 
qRT-PCR ................................................................................................................................ 20 
Statistical Analysis ................................................................................................................. 21 
Gene Ontology ....................................................................................................................... 21 
Western Blot Analysis ............................................................................................................ 21 
ESR1 Immunohistochemistry ................................................................................................. 22 
sPLA2 and DKK1 Immunohistochemistry ............................................................................. 23 
RESULTS ..................................................................................................................................... 25 
Microarray Analysis .............................................................................................................. 25 
qRT-PCR ................................................................................................................................ 25 
Western Blots ......................................................................................................................... 43 
Immunohistochemistry ........................................................................................................... 45 
DISCUSSION ................................................................................................................................ 48 
CHAPTER III: DISCUSSION ...................................................................................................... 54 
JUXTAPOSED WITH ANOTHER ZINC FINGER PROTEIN 1-LIKE (JAZF1) ......................................... 54 
! viii!
SECRETORY PHOSPHOLIPASE A2 (SPLA2) ................................................................................. 55 
S100 CALCIUM BINDING PROTEIN G (S100G) ............................................................................. 57 
ESTROGEN RECEPTOR 1 (ESR1) ................................................................................................. 59 
SOLUTE CARRIER FAMILY 36 (PROTON/AMINO ACID SYMPORTER), MEMBER 2 (SLC36A2) ........ 60 
METHYLTRANSFERASE-LIKE PROTEIN 7A-LIKE (METTL7A) .................................................... 61 
RETINALDEHYDE DEHYDROGENASE 1-LIKE (RALDH1) ............................................................. 62 
EUKARYOTIC TRANSLATION INITIATION FACTOR 2-ALPHA KINASE 3 (EIF2AK3) ....................... 63 
DICKKOPF 1 HOMOLOG (DKK1) ................................................................................................. 64 
ADRENOMEDULLIN (ADM) ........................................................................................................ 66 
PATHWAY ANALYSIS .................................................................................................................. 68 
CONCLUSION .............................................................................................................................. 70 
CHAPTER IV: REFERENCES .................................................................................................... 71 
APPENDICES ............................................................................................................................... 81 
! ix!
LIST OF TABLES 
 
 
Table 1: Maternal Recognition of Pregnancy in Various Species ................................................... 9 
Table 2: Endometrial Sampling Design Layout ............................................................................ 16 
Table 3: Microarray Results for Days 14, 16, and 18 with Higher Expression in Endometrium 
from Pregnant Mares ..................................................................................................................... 26 
Table 4: Microarray Results for Days 14, 16, and 18 with Lower Expression in Endometrium 
from Pregnant Mares ..................................................................................................................... 28 
Table 5: Microarray and qRT-PCR Results Summarized ............................................................. 43 
Table 6: Designed PCR Primers for Identified Genes ................................................................... 82 
  
! x!
LIST OF FIGURES 
 
 
Figure 1: Key Events in Equine Pregnancy ..................................................................................... 6 
Figure 2: Day 12 Endometrial mRNA qRT-PCR Results ............................................................. 29 
Figure 3: Day 14 Endometrial mRNA qRT-PCR Results ............................................................. 30 
Figure 4: Day 16 Endometrial mRNA qRT-PCR Results ............................................................. 31 
Figure 5: Day 18 Endometrial mRNA qRT-PCR Results ............................................................. 32 
Figure 6: JAZF1 Endometrial mRNA Relative Expression Across Days ..................................... 33 
Figure 7: sPLA2 Endometrial mRNA Relative Expression Across Days ..................................... 34 
Figure 8: S100G Endometrial mRNA Relative Expression Across Days ..................................... 35 
Figure 9: ESR1 Endometrial mRNA Relative Expression Across Days ....................................... 36 
Figure 10: SLC36A2 Endometrial mRNA Relative Expression Across Days .............................. 37 
Figure 11: METTL7A Endometrial mRNA Relative Expression Across Days ............................. 38 
Figure 12: RALDH1 Endometrial mRNA Relative Expression Across Days ............................... 39 
Figure 13: EIF2AK3 Endometrial mRNA Relative Expression Across Days .............................. 40 
Figure 14: DKK1 Endometrial mRNA Relative Expression Across Days .................................... 41 
Figure 15: ADM Endometrial mRNA Relative Expression Across Days ..................................... 42 
Figure 16: Western Blot Analysis for sPLA2 ................................................................................ 44 
Figure 17: Western Blot Analysis for DKK1 ................................................................................ 44 
Figure 18: ESR1 Localization in the Endometrium from Pregnant and Non-Pregnant Mares ..... 45 
Figure 19: sPLA2 Localization in the Endometrium from Pregnant and Non-Pregnant Mares ... 46 
Figure 20: DKK1 Localization in the Endometrium from Pregnant and Non-Pregnant Mares .... 47 






















CHAPTER I: REVIEW OF LITERATURE 
Introduction 
 Maternal recognition of pregnancy (MRP) in all species is a sensitive process that 
involves communication between a conceptus and the maternal endometrium. In the horse, this 
communication is even more critical because there is no attachment of the conceptus to the 
endometrium prior to day 35 post-ovulation. Maternal recognition of pregnancy is critical so that 
the endometrium does not secrete prostaglandin F2α (PGF), lysing the corpus luteum (CL) and 
destroying the source of progesterone, the hormone necessary to sustain a pregnancy. Pregnancy 
and the estrous cycle is well understood, but there is a lack of knowledge and understanding of 
how MRP occurs in the mare. In most other species, the signal for recognition of pregnancy has 
been identified. Understanding this signaling is essential for the equine industry to decrease the 
incidence of early embryonic loss, which is the loss of a pregnancy between days 0-35 post-
ovulation. Understanding the genes that are effected by MRP is critical to determine the 
signaling that is occurring during maternal recognition of pregnancy in the mare and may lead to 
discovery of the source of the signal and the mechanisms that allow a pregnancy to be sustained.  
Equine Estrous Cycle 
 The estrous cycle in the mare is on average 21 days long, with day 0 being the day of 
ovulation. It is comprised of a luteal phase and a follicular phase, which is further divided into 
metestrus, diestrus, proestrus, and estrus. The luteal phase is progesterone dominated and the 
follicular phase is estrogen dominated. In both pregnant and non-pregnant mares the hormonal 
profiles are the same until day 14, which is when the endometrium has recognized the presence 
or absence of a conceptus (Sharp et al. 1997). Prostaglandin F2α, from the endometrium, is the 
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hormone responsible for the demise of the CL in the absence of a conceptus, known as luteolysis 
(Sharp et al. 1997). Oxytocin is the stimulator for the release of PGF from the endometrium 
(Burns et al. 1997). Towards the end of the luteal phase (day 14), endometrial progesterone 
receptors are down regulated. This results in an up regulation of estrogen receptors and 
subsequently an up regulation of oxytocin receptors (McCracken et al. 1999). Estrogen causes 
hypothalamic oxytocin pulses to occur. This oxytocin then binds to the endometrium causing the 
endometrium to start secreting more oxytocin (McCracken et al. 1999).  Circulating levels of 
oxytocin are highest during the mid and late luteal phase and lowest during ovulation and early 
diestrus (Tetzke et al. 1987). The combination of the hypothalamic pulses of oxytocin and 
secretion of endometrial oxytocin causes the production and secretion of endometrial PGF 
(McCracken et al. 1999). Administration of oxytocin during late diestrus also induces an 
immediate rise in the major PGF metabolite, PGFM (Goff et al. 1987).  
 PGF is metabolized from arachadonic acid. Upon oxytocin stimulation, arachadonic acid 
is secreted from the phospholipid bilayer. It is then converted to prostaglandin H2 (PGH2) by 
one of two enzymes (Needleman et al. 1986). These two enzymes are prostaglandin-
endoperoxide synthase 1 or 2 (PTGS1 or PTGS2), previously known as cyclooxygenase 1 or 2 
(COX1 or COX2) respectively (Needleman et al. 1986). PTGS1 is the constitutive isoform of the 
enzyme and its levels remain unaltered throughout the estrous cycle, independent of pregnancy 
status (Boerboom et al. 2004). PTGS2 is the inducible form that increases in mRNA and protein 
levels corresponding with luteolysis (Needleman et al. 1986; Boerboom et al. 2004). The 
increase in PTGS2 protein is not observed in pregnant mares (Boerboom et al. 2004). 
Prostaglandin F2α synthase converts PGH2 into PGF (Needleman et al. 1986). PGF then enters 
peripheral circulation and eventually reaches the ovaries (Allen and Stewart 2001). This results 
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in the lysis of the CL and the continuation of the estrous cycle (McCracken et al. 1999). This 
process is also observed in vitro when endometrial cells are stimulated with oxytocin causing the 
release of PGF (Ealy et al. 2010). Eventually there is reduced responsiveness of the endometrium 
to oxytocin, which also coincides with a decreased binding capacity of the endometrium for 
oxytocin (Starbuck et al. 1998). During pregnancy, oxytocin responsiveness is altered indicating 
that adjustment of the PGF release mechanism contributes to the maintenance of the CL. Day 14 
pregnant mares respond with a diminished release of PGFM following oxytocin administration, 
indicating that the PGF release mechanism has been altered (Goff et al. 1987). PGF release 
occurs throughout the entire uterine body, therefore it is necessary that the entire endometrial 
surface is exposed to the conceptus derived pregnancy recognition signal in order to prevent 
oxytocin and PGF release (Ginther 1974). 
Early Pregnancy in the Mare 
 After ovulation, the oocyte travels into the oviduct where fertilization occurs. From there 
the conceptus stays in the oviduct until day 6 (Weber et al. 1991a). To relax the smooth muscle 
in the oviduct at the utero-tubal junction and enter the uterus, the conceptus secretes 
prostaglandin E2 (PGE) (Allen 2001). This secretion begins at day 4.5, or when the conceptus 
becomes a compact morula (Weber et al. 1991a; 1991b; 1992; Allen 2001). PGE is synthesized 
in the same manner as PGF, except that prostaglandin E2 synthase converts PGH2 to PGE 
(Needleman et al. 1986). It has a local effect and causes the relaxation of the circular smooth 
muscle in the oviduct (Allen 2001). Intrauterine administration of PGE also causes increased 
uterine tone and contractility (Gastal et al. 1998). As the conceptus enters the uterus, it is a late 
stage morula or an early blastocyst (Betteridge et al. 1982). Upon blastulation, the conceptus 
starts to develop a capsule underneath the zona pellucida (Betteridge et al. 1982). The capsule is 
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made up of glycoproteins resembling those of the mucin family with sialic acid making up most 
of the carbohydrate content (Klein and Troedsson 2011b). On day 9, there is a change in the 
glycosylation characteristics, ultimately resulting in the loss of the zona pellucida, and leaving 
the capsule surrounding the conceptus (Oriol et al. 1993). The capsule is essential for embryo 
survival. When it is removed from day 6-7 embryos and the embryo then placed into a recipient 
mare there is no establishment of pregnancy (Stout et al. 2005). The capsule will remain 
surrounding the embryo until day 16 when the sialic acid decreases, which also corresponds to 
fixation. For this reason, it is thought that the capsule acts as an anti-adhesive. The capsule starts 
to disappear on day 22.5 and is completely gone by day 24.5 (Oriol et al. 1993).  
 On day 9, there is minimal movement throughout the uterus by the conceptus, but by day 
10, mobility dramatically increases (Ginther 1983b). This movement is thought to be caused by 
conceptus derived estrogens stimulating the release of a small amount of PGF and causing slight 
contractions (Stout and Allen 2001). If a cyclo-oxygenase (COX) inhibitor is administered to 
mares between days 10-16 it results in a significant decrease in conceptus mobility (Stout and 
Allen 2001). Maximum embryo mobility is between days 11-14, which corresponds to the time 
of maternal recognition of pregnancy (Ginther 1983b). Movement throughout the majority of the 
uterus is essential in order to delay PGF release from the endometrium (Ginther 1974). If the 
conceptus is restricted to less than two-thirds of the endometrial surface it leads to pregnancy 
failure, but this effect can be rescued by supplementing with exogenous progesterone (McDowell 
et al. 1988). During this time period the uterine tone increases, causing a change in the 
contractile pattern of the myometrium. It is thought the mobile conceptus is causing these 
changes (Gastal et al. 1996).  
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 The conceptus ceases mobility at day 16 (Leith and Ginther 1984), and is referred to as 
fixation (Ginther 1983a). The conceptus fixes, but does not attach or implant, at the base of one 
of the uterine horns, independent of the side of ovulation (Gastal et al. 1996). There are many 
different factors that cause fixation. There is a sudden spasm-like increase in myometrial tone 
that occurs at this time (Ginther 1983b). Also, there is an increase in uterine tone and the size of 
the conceptus increases (Gastal et al. 1996). All of these factors result in the cessation of 
movement and the fixation of the conceptus.  
 As expected, due to the presence of a mobile conceptus, PGF concentrations at day 10 
and day 14 of pregnancy are lower than the corresponding days in a cyclic mare (Douglas and 
Ginther 1976). Uterine flushings from mares beyond day 18 of pregnancy contain PGF 
concentrations similar to those seen during luteolysis, indicating that the conceptus only delays, 
rather than prevents the production of uterine PGF (Stout and Allen 2002). Also, when 
endometrium from a pregnant mare is obtained, in the absence of the conceptus, it will start to 
secrete the same amount of PGF as the endometrial tissue from a non-pregnant mare (Vernon et 
al. 1981; Watson and Sertich 1989). This suggests that the constant stimulation from the 
conceptus is critical for maternal recognition of pregnancy. When endometrial explants from 
non-pregnant mares are cultured in the same media that previously contained a conceptus there is 
a dramatic decrease in PTGS2, the inducible form of PTGS in PGF synthesis (Ealy et al. 2010). 
This indicates that not only the stimulation of the conceptus is critical, but also that it is secreting 
a factor that affects the endometrium. The conceptus remains fixed, but does not implant, in the 
uterus until day 36 of pregnancy. At day 36 the trophoblast cells become invasive and migrate 
into the maternal endometrium forming endometrial cups. These endometrial cups secrete equine 
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chorionic gonadotropin, which results in the luteinization of follicles on the ovary and an 
increase in progesterone secretion (Allen and Stewart 2001).  
  
Figure 1: Key Events in Equine Pregnancy 
 
Key events in a normal pregnancy. Day 0 is the day of ovulation. On day 6, the embryo 
secretes prostaglandin E2 allowing the oviduct to relax and the embryo to enter the uterus. 
Embryo mobility starts on day 9 and continues until day 16 when the embryo fixes at the 
base of one of the uterine horns. Maternal recognition of pregnancy (MRP) is occurring 
between days 12-14. The embryo does not implant into the uterus until day 36 with the 
invasion of the endometrial cups. If MRP does not occur, luteolysis begins on day 14 
with the mare returning to estrus by day 18. 
 
Maternal Recognition of Pregnancy in Other Species 
 In many species, MRP is well defined. Maternal recognition of pregnancy is essential to 
extend the lifespan of the functional CL and to continue its synthesis and secretion of 
progesterone. Progesterone is required for secretory functions of the endometrium, embryonic 
development, implantation, and placentation (Bazer et al. 2008). There are two categories of 
mechanism of maternal recognition, luteotrophic or anti-luteolytic. Luteotrophic directly 
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promotes luteal function, supporting the CL, and anti-luteolytic prevents the uterine release of 
luteolytic PGF, which causes the lysis of the CL. Cattle, sheep, pigs, mice, and humans/non-
human primates are among the most well studied species regarding maternal recognition of 
pregnancy.  
 Humans/non-human primates and rodents maintain luteal function through luteotrophic 
mechanisms. In primates the maternal recognition signal is chorionic gonadotropin (CG) (Ross 
1978). The syncytiotrophoblast cells secrete CG from days 8-10 post-ovulation for pregnancy 
recognition. At the same time, days 7-9, implantation is occurring. Chorionic gonadotropin 
stimulates the CL to produce progesterone until there is a shift between luteal and placental 
progesterone secretion. Once the shift occurs, CG secretion decreases (Bazer et al. 2010). 
Administration of exogenous CG can also extend the luteal function of the CL and increase 
progesterone secretion in humans and non-human primates (Bazer et al. 2008). Rodents also 
maintain luteal function through luteotrophic mechanisms, with prolactin being the maternal 
recognition of pregnancy signal (Frasor and Gibori 2003). Prolactin, from the anterior pituitary 
gland, is induced by mating (Soares 2004). It is the initial maternal recognition signal until day 
12 of pregnancy. After day 12 the conceptus and uterine decidua take over stimulating 
progesterone secretion by secreting lactogenic hormones (prolactins) (Soares 2004). These 
hormones act on the luteal cells through the prolactin receptors to maintain luteal cell function 
and the secretion of progesterone (Soares 2004).  
 The other mechanism for maternal recognition of pregnancy is an anti-luteolytic 
mechanism. The MRP signal for cattle and sheep is interferon-tau (IFNt) (Bazer et al. 1997). In 
sheep, IFNt is secreted between days 10-21 by the mononuclear trophoblast cells (Bazer et al. 
1997). On days 11-16, the PGF concentrations are the same in pregnant and non-pregnant 
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animals, but pregnant animals administered PGF on day 19 or 20 do not return to estrus (Pratt et 
al. 1977; Bazer et al. 2008).  Interferon-tau has a local effect and blocks the expression of 
estrogen and oxytocin receptors (Bazer et al. 1997). With the lack of estrogen and oxytocin 
receptors, the PGF synthesis pathway is not stimulated, which results in little PGF synthesis. 
There is also an increase in intrauterine PGE during pregnancy (Pratt et al. 1977). Interferon-tau 
is also the MRP signal in cattle (Bazer et al. 1997). It is secreted between days 12-38 of 
pregnancy (Bazer et al. 1997). Interferon-tau acts in the same manner in cattle as it does in sheep, 
by suppressing the transcription of estrogen receptor, therefore decreasing estrogen induced 
oxytocin receptor, decreasing the PGF cascade (Bazer et al. 1997). Ovarian follicular 
development is suppressed in the ovary with the CL, but not the contralateral CL. This also 
results in decreased levels of estrogen (Bazer et al. 1997).  
 Pigs also have an anti-luteolytic mechanism of maternal recognition of pregnancy and 
this signal is estrogen (Bazer and Thatcher 1977). Estrogen is produced by the conceptus on days 
11 and 12 (Ziecik 2002). Estrogen does not cause a decrease in PGF secretion from the 
endometrium, but instead redirects PGF secretion from the uterine vasculature to the uterine 
lumen. The PGF is sequestered and metabolized in the uterine lumen to prevent it from reaching 
the CL and initiating luteolysis (Bazer and Thatcher 1977). There is also a shift in the ratio of 
PGF secretion to PGE secretion. Intrauterine application of PGE delays the lysis of the CL 
(Akinlosotu et al. 1986). PGF and PGE exert opposing actions on the CL, and each play a critical 
role in luteolysis or the maintenance of a pregnancy. Estrogen secretion from the conceptus 
stimulates the secretion of PGE, a luteoprotectant, from the endometrium. Prostaglandin E2 acts 
in a positive feedback loop, which results in more PGE production. This keeps prostaglandin 
synthesis towards PGE and not PGF (Waclawik 2011).  
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Table 1: Maternal Recognition of Pregnancy in Various Species 
 





Bovine Interferon Tau Anti-luteolytic (Bazer et al. 1997) 
Ovine Interferon Tau Anti-luteolytic (Bazer et al. 1997) 
Porcine Estrogen Anti-luteolytic (Bazer and Thatcher 1977) 





Luteotrophic (Ross 1978) 
 
Maternal Recognition of Pregnancy in the Mare 
 While MRP is well understood in many species, it remains a mystery in the horse. It is 
thought that during the pre-implantation phase the conceptus interacts with the uterine 
environment with paracrine signals in order to eventually coordinate attachment and 
implantation. Because implantation does not occur until day 35 in horses, the conceptus must 
signal its presence to the endometrium in order to inhibit luteolysis and allow progesterone 
secretion to continue (Bauersachs and Wolf 2012). Without this MRP, luteolysis will occur and 
pregnancy will be terminated due to the lack of progesterone. Different time frames have been 
investigated to determine when maternal recognition of pregnancy occurs. In a previous 
experiment, oxytocin was administered on day 8 post-ovulation to attempt to trigger the PGF 
synthesis pathway and initiate luteolysis. It was concluded that the oxytocin luteolytic 
mechanism was not in place by day 8 because administration of oxytocin failed to elicit a 
response and induce luteolysis (Neely et al. 1979). This means that MRP is occurring after day 8. 
There is also no differential gene expression in the endometrium between day 8 pregnant and 
non-pregnant mares (Merkl et al. 2010). It was also noted that frequent or continuous 
administration of oxytocin during the luteal phase blocked luteolysis, implying that MRP results 
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in alteration and functionality of the oxytocin receptor inhibiting its effect on luteolysis 
(Vanderwall et al. 2007). It has also been shown that continuous high systemic doses of oxytocin 
initiated prior to day 10 results in the prolongation of the luteal phase. These results imply that 
MRP must be initiated by day 10 (Stout et al. 1999).  
Administration of oxytocin on days 7-14 post-ovulation also resulted in prolonged 
diestrus (Gee et al. 2012). This is further confirmed with the endometrium developing 
responsiveness to oxytocin administration on day 11 (Goff et al. 1987). By day 12 there is 
differential gene expression in the endometrium between pregnant and non-pregnant mares 
(Merkl et al. 2010). These genes are involved in angiogenesis and vascular remodeling, which is 
necessary for the endometrium to prepare for pregnancy and support conceptus growth (Klein et 
al. 2010). By day 13, repression of PTGS2 is noted, indicating the MRP signal is on or before 
day 13 (Boerboom et al. 2004). Day 13.5 endometrium also has differential gene expression 
between pregnant and non-pregnant mares. Some of the genes identified have also been 
identified to be involved in maternal recognition of pregnancy in other species. Most of the up 
regulated transcripts were secreted proteins and genes involved in transport and cell-signaling 
(Klein et al. 2010). Finally, an increase in PGF secretion is observed 14 days after ovulation, 
ultimately resulting in lysis of the corpus luteum (Sharp et al. 1997). All of these data indicate 
that MRP is occurring after day 10 but before day 14 in order to prevent luteolysis.  
 Since the conceptus secretes PGE to relax the smooth muscle in the oviduct allowing it to 
enter the uterus (the first signal of MRP in the horse), it was thought that PGE may be the MRP 
signal (Allen 2001). Intrauterine infusion with PGE resulted in no change in luteal function 
(Vanderwall et al. 1994) and there was no increase of PGE in uterine flushings or endometrial 
tissue associated with pregnancy indicating that PGE is not the MRP signal (Watson and Sertich 
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1989). Next researchers evaluated interferons like those expressed by ruminant conceptuses. 
Alpha 1, omega 1, and omega 2 interferons were not expressed in equine conceptuses, therefore 
not following the same mechanism as ruminants (Baker et al. 1991). Estrogen was evaluated to 
determine its effect as the MRP signal and ultimately oxytocin receptor expression. In two 
separate experiments, it was shown that intrauterine estradiol injection did not delay or inhibit 
luteolysis in the non-pregnant mare (Goff et al. 1993; Vanderwall et al. 1994). This again 
showed that estrogen was not the signal for MRP. Recently, the administration of plant oils and 
fractionated coconut oils resulted in luteal persistence in 92% of mares treated on day 10, but not 
the same results were seen in mares treated on days 6, 8, 12, and 14. It was thought that these oils 
inhibited PTGS2 (Wilsher and Allen 2011).  
 Researchers also evaluated gene expression profiles of equine conceptuses before, during, 
and after MRP. There was enhanced expression of genes involved in cholesterol transport, 
suggesting active synthesis of steroid hormones (Klein and Troedsson 2011a). Interestingly, 
there was a down regulation in genes involved in the stimulation of the immune system, 
suggesting the need for the conceptus to be protected from the maternal immune system (Klein 
and Troedsson 2011a). There was also an up regulation of fibrinogen α, β, and γ. It was thought 
the fibrinogen chains were released from the conceptus and acted on the endometrium (Klein and 
Troedsson 2011a). Down regulation of plasminogen activator and antiplasmin precursor, 
combined with up regulation of plasminogen activator inhibitor was identified in endometrium 
from pregnant mares. It was thought this system was affected in order to prevent erosion of the 
equine endometrium during pregnancy (Klein and Troedsson 2011a).  
 Finally, researchers wanted to evaluate the size and type of molecule utilized for MRP. 
To do this day 14 conceptuses were placed in dialysis bags with permeability to different 
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molecular weights and then co-incubated with endometrial explants. This narrowed the size of 
the signal down to be greater than 1000 Daltons, but less than 10,000 Daltons (Klein and 
Troedsson 2011b). The factor was later further specified to a size between 1000-6000 Daltons 
(Sharp et al. 1989). The conceptus secretions were treated with proteinase K and dextran-coated 
charcoal. The proteinase K had no effect on the anti-luteolytic activity, but the dextran-coated 
charcoal resulted in the removal of the anti-luteolytic activity. From this experiment, it was 
concluded that the MRP signal in horses was a size between 3000-6000 Daltons that is 
proteinase K resistant, but may be absorbed by dextran-coated charcoal (Klein and Troedsson 
2011b). While a lot of information is known about the timing of the MRP signal, and what it is 
not, it still remains a mystery as to the actual identity of this signal. 
Early Embryonic Loss 
 Early embryonic loss has a high prevalence in the equine industry and is defined as 
pregnancy loss prior to day 35 post-ovulation, or implantation. Fertilization rates in the horse are 
very high and approach 90%, but 77.1% of all pregnancies are lost prior to day 35 (Villahoz et al. 
1985; Ball et al. 1986). The time interval with the largest loss is between days 11-15 post-
ovulation. This accounts for 18.29% of mares that were diagnosed as pregnant on day 11 and no 
embryos were present on day 15 (Ginther et al. 1985). Of those 18.29%, 29% became 
pseudopregnant. This was thought to occur due to particles of the embryonic vessel still present 
in the uterine lumen and stimulating MRP (Ginther et al. 1985). In a separate study, 13.28% of 
mares suffered from early embryonic loss. Of those mares, 47.05% of pregnancies were lost 
prior to day 19 (Papa et al. 1998). Early embryonic loss accounts for 20% of the losses in fertile 
mares and 70% of the losses in subfertile mares (Carnevale et al. 2000).  
! 13!
 Many factors are thought to cause early embryonic loss. The losses that are occurring 
prior to day 15 are thought to be due to the failure of MRP (Ginther et al. 1985). Endometrial 
disease (endometritis) is considered another major cause (Carnevale et al. 2000). Endometritis 
could be causing secondary luteolysis, resulting in the loss of the pregnancy (Ginther et al. 1985). 
Primary dysfunction of the corpus luteum is not the cause of early embryonic loss because 
plasma progesterone levels were similar between pregnant mares and mares suffering from early 
embryonic loss. The progesterone concentrations did not change until after early embryonic loss 
meaning the progesterone drop is an effect, not a cause, of the early embryonic loss (Papa et al. 
1998). Another hypothesis is as the conceptus is triggering uterine contractility by PGF it may 
stimulate too much secretion resulting in the PGF entering the uterine vein and initiating 
luteolysis of the corpus luteum (Allen and Stewart 2001). Other factors to embryonic loss 
include nutrition, body condition, stallion, chromosomal abnormalities, hormonal deficiencies, 
stress, immune factors, and failure of the MRP signal at the appropriate time (Carnevale et al. 
2000). 
Conclusion 
 Maternal recognition of pregnancy in the mare is a delicate and complex process that is 
still not well understood. The exact signal and mechanism for maternal recognition of pregnancy 
that occurs prior to day 14 post-ovulation remains unknown. It is known that the embryo must be 
mobile and come in contact with over two-thirds of the endometrium, the signal acts in an anti-
luteolytic manner, and the signal is between 1000-6000 Daltons. The goal of this study is to 
evaluate the expression patterns of ten genes identified using an equine specific microarray 
(Bruemmer et al. 2010) during and after maternal recognition of pregnancy in pregnant and non-
pregnant mares.   
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CHAPTER II: PROFILING GENE EXPRESSION IN EQUINE ENDOMETRIUM DURING 
MATERNAL RECOGNITION OF PREGNANCY (DAYS 12, 13, 14, 16, AND 18) 
Summary 
The mechanism for equine maternal recognition of pregnancy is unknown. To maintain a 
pregnancy, the presence of a mobile conceptus prior to day 14 post ovulation (PO) must be 
identified to prevent endometrial secretion of prostaglandin F2α (PGF) on days 14-16 PO, 
initiating luteolysis. Previously, an equine specific microarray analysis was performed on days 
14, 16, and 18 PO comparing endometrium from pregnant and non-pregnant mares. Ten genes 
were identified as being consistently higher or lower expressed in endometrium from pregnant 
mares at each day. For this experiment, gene expression on days 12, 14, 16, and 18 PO was 
analyzed with real time PCR (RT-PCR) to analyze the microarray genes. Twelve normally 
cycling mares were used in a crossover design and were randomly assigned to a collection day 
(day 12, 14, 16, or 18 PO), providing endometrial samples from a pregnant and non-pregnant 
(non-mated) cycle (n=3 per day). Endometrial samples were snap frozen and total RNA was 
isolated for RT-PCR.  Day 14, 16, and 18 were consistent with the microarray analysis, but on 
day 12, six of the ten differentially expressed genes had the same pattern of expression as day 14, 
and four of the genes had opposite expression patterns. Endometrial samples were then collected 
on day 13 PO (n=3) and processed for protein isolation and immunohistochemical (IHC) analysis. 
sPLA2 and DKK1 antibody specificity were assessed by Western Blot analysis and cellular 
localization was examined by IHC. These are the first data to describe gene expression and 
cellular localization in the endometrium at the time of maternal recognition of pregnancy for 
these genes. The pathway and functions of these genes may be critical in identifying the signal 
for maternal recognition of pregnancy in the mare.  
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Introduction 
 The interaction of the embryo with the endometrium of the equine uterus during maternal 
recognition of pregnancy is critical to prevent luteolysis, allowing the corpus luteum (CL) to 
remain intact and continue progesterone secretion. The mobility of the embryo throughout the 
entire uterine lumen is critical to initiate this anti-luteolytic process. In a prior experiment 
(Bruemmer et al. 2010), endometrial gene expression during and after maternal recognition of 
pregnancy (days 14, 16, and 18) was analyzed using an equine specific mircoarray containing 
over 42,000 probes. Analysis led to identification of 10 genes that were significantly (P<0.001) 
up or down regulated (fold change ≥ 3) in pregnant mares on all days studied (days 14, 16, and 
18). These genes were also consistent in their expression levels over the three time points. Using 
those results, in this study the ten genes were evaluated by quantitative Reverse Transcriptase 
Polymerase Chain Reaction (qRT-PCR) on days 12, 14, 16, 18 to confirm and expand upon the 
microarray analysis. We hypothesized that on day 12 the expression patterns of the identified 
genes would be the same as on days 14, 16, and 18.  
Materials and Methods 
Horse Care 
 The Colorado State University Institutional Care and Use Committee approved all horse 
use. Mares (n=15) were used in a simple crossover design where each mare had a pregnant and 
non-pregnant (non-mated) cycle. Mares were monitored via transrectal palpation and 
ultrasonography to track their follicular development every other day. Once a follicle reached the 
size of 35mm or greater the mare was inseminated with at least 500x106 progressively motile 
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sperm/mL from stallions with known fertility.  The mare was evaluated via transrectal 
ultrasonography every day and inseminated every other day until ovulation (day 0) was detected.  
Experimental Design 
 Mares were utilized in a crossover design with each mare being sampled in a pregnant 
cycle then a non-pregnant (non-mated) control cycle. Mares were randomly assigned to one 
collection day (day 12, 13, 14, 16, or 18 post-ovulation). Days 12, 14, 16, and 18 endometrial 
samples were obtained in the same year while day 13 endometrial samples were obtained the 
following year. Table 2 describes the design of this study. 
Table 2: Endometrial Sampling Design Layout 
 Day 12 Day 13 Day 14 Day 16 Day 18 
Mare P+ NP P+ NP P+ NP P+ NP P+ NP 
1 X X         
2 X X         
3 X X         
4   X X       
5   X X       
6   X X       
7     X X     
8     X X     
9     X X     
10       X X   
11       X X   
12       X X   
13         X X 
14         X X 
15         X X 
 
Endometrial Biopsy Collection for Days 12, 14, 16, and 18 
 Mares were randomly assigned (n=3 per day) to a collection day (day 12, 14, 16, or 18 
post-ovulation). On the specified collection day the mare was evaluated via transrectal 
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ultrasonography to confirm pregnancy status by the visualization of an embryonic vesicle. 
Endometrial samples were obtained non-surgically via trans-cervical biopsy punch. Each sample 
was rinsed in DPBS/Modified 1X (HyClone Laboratories, Inc., Logan UT) and split in half. Half 
of the sample was placed in TRI Reagent (Molecular Research Center, Cincinnati, OH) and 
frozen at -80°C until RNA isolation. The other half of the sample was snap frozen in liquid 
nitrogen and transferred to the -80°C until RNA isolation. This process was repeated for each 
mare through a non-bred cycle. 
Endometrial Biopsy Collection for Day 13 
 Mares were randomly assigned (n=3) to collection day 13 post-ovulation. On the 
specified collection day the mare was evaluated via transrecetal ultrasonography to confirm 
pregnancy status by the visualization of an embryonic vesicle. Endometrial samples were 
obtained via trans-cervical biopsy punch. Each sample was rinsed in DPBS/Modified 1X 
(HyClone Laboratories, Inc., Logan, UT) and split into thirds. A third of the sample was placed 
in TRI Reagent (Molecular Research Center, Cincinnati, OH) and frozen at -80°C until RNA 
isolation, a third of the sample was snap frozen in liquid nitrogen and stored at -80°C until RNA 
isolation, and the last third of the sample was prepared to be embedded in paraffin for 
histological analysis by light microscopy. For light microscopy, the sample was cut in-to sections 
no larger than 1.5 cm. The sections were then placed in 4% paraformaldehyde (Affymetrix, Inc., 
Cleveland, OH) in a ratio of one part tissue to ten parts fixative and left at room temperature for 
one hour. They were then left at 4°C overnight. The next day, the fixative was replaced with 70% 
ethanol for storage. When all samples were collected and fixed they were sent to the Colorado 
State Veterinary Diagnostics Laboratory in Fort Collins, CO, where to be embedded in paraffin 
blocks.  
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RNA Isolation and Quantification 
 Total RNA was isolated using TRI Reagent (Molecular Research Center, Cincinnati, OH) 
for lysis and the RNeasy Mini Kit for RNA isolation (Qiagen, Valencia, CA, Catalog #74104). 
Frozen tissue samples (about 30mg) were homogenized in Tri Reagent and left at room 
temperature for 10 minutes. Chloroform was then added to the homogenate, vortexed and left a 
room temperature for 8 minutes. The sample was then centrifuged at 13,200 revolutions per 
minute for 15 minutes, separating the sample in to three distinct layers (RNA phase, DNA phase, 
protein phase). The top RNA aqueous phase was transferred to a new 1.7mL tube and the DNA 
and protein phase was stored at -80°C for future protein isolations. The remaining RNA cleanup 
protocol followed the manufacturer’s recommendation for the Qiagen RNeasy Mini Kit (Qiagen, 
Valencia, CA, Catalog #74104) with the use of an RNeasy Mini spin column. All samples were 
treated with RNase-Free DNase set (Qiagen, Valencia, CA, Catalog #79254) to remove any 
DNA contamination. RNA purity and quantification were assessed using the NanoDrop 
Spectrophotometer ND-1000 (Thermo Scientific, Wilmington, DE). Samples were accepted if 
they had 260/280 and 260/230 values above 1.7 for PCR, and samples were used for subsequent 
analysis. 
Protein Isolation and Quantification 
 Protein isolation was performed utilizing RIPA lysis buffer (Appendix I). Samples (about 
30mg) were homogenized in RIPA lysis buffer. The sample was placed at 4°C until bubbles 
broke apart. Samples were then sonicated on ice to break apart remaining cells. The remaining 
particles were pelleted at 10,000 revolutions per minute at 4°C for 10 minutes and the 
supernatant containing the protein was placed in a separate 1.7mL eppendorf tube. Proteinase 
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inhibitor cocktail (PIC) and phenylmethanesulfonyl fluoride (PMSF) were added to each sample 
(Appendix I). Samples were quantified following manufacturer’s protocol for the Pierce BCA 
Protein Assay Kit (Thermo Scientific, Wilmington, DE, catalog #23227). Standards were 
prepared using the manufacturer provided bovine serum albumin at 2.0 mg/mL. Working reagent 
utilizing manufacturer’s reagents A and B was prepared. A microplate was loaded with 25 µL of 
standard or unknown and 200 µL of working reagent. The microplate was then incubated for 30 
minutes at 37°C. Samples were quantified using spectrophotometry with the Synergy 2 Multi-
Mode Microplate Reader (Biotek, Winooski, VT). Sample concentrations were determined based 
upon the standard curve prepared with the standards. If concentrations were below 1.0 µg/µL the 
sample was reisolated. The samples were stored at -80°C until further analysis.  
Reverse Transcription 
 cDNA was created using iScript cDNA Synthesis Kit (Bio-Rad, Hercules, CA, Catalog 
#170-8890) using the manufacturer’s protocol. A 20µL reaction was made up with 4µL of 5x 
iScript reaction mix, 1µL of iScript reverse transcriptase, 1µg of RNA template, and nuclease-
free water. It was incubated for 5 minutes at 25°C, 30 minutes at 42°C, and then 5 minutes at 
85°C. The cDNA was then immediately added to the qRT-PCR reaction mix for PCR analysis.  
Sequencing 
Equine specific PCR forward and reverse primers were designed using Primer3 
(http://primer3.wi.mit.edu/) with a product size between 115-135 base pairs, a primer length 
between 19-27 base pairs, a primer Tm between 60-65°C, and a GC% content between 40-60. 
Designed primers for each of the genes can be found in Appendix II. Each product was 
sequenced to verify the specificity of the primer. cDNA was generated from the RNA template 
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from endometrial samples using the same protocol as the cDNA for qRT-PCR. A 10µL PCR 
reaction mix was generated using 5.7µL of nuclease free water, 2.0µL of 5x GoTaq buffer 
(Promega, Madison, WI, Catalog #M791A), 0.1µL GoTaq DNA polymerase (Promega, Madison, 
WI, Catalog #M300A), 0.2µL of 10mM dNTP mix (Quanta Biosciences, Gaithersberg, MD, 
Catalog #84032), 1.0µL of cDNA, and 1µL of 5µM primer in 10mM Tris-HCl. The reaction was 
incubated at 94°C for 5 minutes, then 40 cycles consisting of 15 seconds at 94°C, 30 seconds at 
60°C and 15 seconds at 72°C, and then a final incubation for 3 minutes at 72°C. PCR products 
were run through a 2% agarose gel to identify the PCR products. The PCR products were 
isolated from the gel following manufacturer’s recommendation for the Qiaquick Gel Extraction 
Kit (Qiagen, Valencia, CA, Catalog #28704). The PCR product was excised from the gel and 
dissolved in buffer QG. Isopropanol was added and the sample was then placed in a Qiaquick 
spin column. The sample was washed with buffer PE to rinse away remaining gel and eluted in 
nuclease-free water. Samples were then prepared to be sent to sequencing at the Colorado State 
University Proteomics and Metabolomics Facility, Fort Collins, CO.  
qRT-PCR 
 The validated primers were used to analyze the mRNA expression levels of the samples 
with qRT-PCR. Two positive controls were used, GAPDH and TUBA1B, and the primer 
sequences are listed in Appendix II. Each reaction was 6µL total with 3µL of SsoAdvanced 
SYBR Green Supermix (Bio-Rad, Hercules, CA, Catalog #1725260), 0.9µL of nuclease-free 
water, 1µL of cDNA at a concentration of 50ng/µL, and 1µL of primer at a concentration of 5µM. 
qRT-PCR was performed using a LightCycler480 PCR system (Roche, Indianapolis, IN). The 
PCR conditions consisted of 30 seconds at 95°C for enzyme activation, 40 cycles consisting of 
denaturation at 95°C for 5 seconds and annealing and extension at 60°C for 30 seconds, and 
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ending in a melt curve analysis of the PCR product at 65-95°C in 0.5°C increments with 2 
seconds at each step. The gene of interest was considered to be present at a Cp value of less than 
37 and each amplicon was evaluated based upon a correct amplification curve and a singular 
melt peak.  
Statistical Analysis 
 Raw Cp values from endometrial samples from pregnant and non-pregnant mares were 
normalized by using the geometric mean of GAPDH and TUBA1B because they have the same 
expression level the same across all time points independent of pregnancy status. The samples 
were then compared using a paired, two-tailed student’s t-test for statistical difference within 
each day. Samples were also analyzed across days 12, 14, 16, and 18 by a one-way ANOVA 
with a Tukey’s Honestly Significant Difference Test (HSD). Samples were considered 
statistically different at P<0.05 for both analyses, within and across days.   
Gene Ontology 
 Gene ontology was evaluated for each gene of interest. Chromosome locations were 
determined for the horse, but gene ontologies were based upon human ontologies. All ontologies 
were determined using AgBase (http://www.agbase.msstate.edu/).  
Western Blot Analysis 
 Western blot analysis was used to determine the specificity of DKK1 and sPLA2 
antibodies that were not designed against equine peptide, but have been used in various species. 
For each western blot, 40µg of endometrial protein from pregnant and non-pregnant mares was 
loaded into each well of a 12% 1.0mm SDS-page polyacrylamide gels (Appendix III). Samples 
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were incubated with a 4:1 6x buffer to DTT mix for 10 minutes at 90°C. Samples were then 
transferred to the wells and run for 30 minutes at 30mA and transferred to Protran nitrocellulose 
membranes (GE Healthcare Life Sciences, Pittsburgh, PA, Catalog #10402468) for 1 hour at 
100V at 4°C. Membranes were blocked in 5% blocking buffer (5% non-fat dried milk in 1X 
TBST) for 1 hour at room temperature and washed with 1X TBST. Membranes were then 
incubated with either primary anti-phospholipase A2 rabbit polyclonal antibody (1:1000 in 5% 
milk TBST, Abcam, San Francisco, CA, ab23705) or primary anti-DKK1 rabbit polyclonal 
antibody (1:1000 in 5% milk TBST, Abcam, San Francisco, CA, ab93017) overnight at 4°C. The 
next day membranes were washed 3 times in 1X TBST and incubated with horseradish 
peroxidase conjugated goat polyclonal secondary antibody to rabbit IgG (1:2000 in 5% milk 
TBST, Abcam, San Francisco, CA, ab6721) for 1 hour at room temperature. Membranes were 
again washed 3 times with 1X TBST and exposed to ECL Plus Western Blotting Detection 
Reagent (GE Healthcare Life Sciences, Pittsburgh, PA, Catalog #RPN2232) for 5 minutes. 
Membranes were imaged for analysis on a Molecular Imager ChemiDoc XRS+ System (Bio-Rad, 
Hercules, CA).  
ESR1 Immunohistochemistry 
 The protocol for immunohistochemistry for ESR1 was adapted from (Wilsher et al. 2011). 
5µm sections of tissue were placed on a slide and incubated overnight at 37°C. Slices were then 
taken through a standard dewaxing and dehydration process using Citrisolve (Thermo Scientific, 
Wilmington, DE, Catalog# 22-143975) and an alcohol gradient. The slices were then blocked 
from endogenous peroxidase with 1% H2O2 in 70% methanol for 30 minutes and rinsed in water. 
Microwave assisted antigen retrieval was performed by boiling slides in 10mM sodium citrate 
buffer (pH 6.0) for 2 bursts of 5 minutes and then left in the hot sodium citrate for 30 minutes. 
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Then they were washed with running water for 5 minutes. Slides were blocked from nonspecific 
binding by incubation with 10% normal goat serum (NGS) in TBS containing 1% bovine serum 
albumin (BSA) in a humidity chamber at room temperature for 30 minutes. The slides were then 
incubated overnight at 4°C in a humidity chamber with primary mouse monoclonal estrogen 
receptor antibody (1:20 in TBS with 1% BSA and 2% NGS, Leica Microsystems, Buffalo Grove, 
IL, Catalog #NCL-ER-6F11). The next day the slides were washed in TBS with BSA solution 
and the horseradish peroxidase conjugated bioatinylated goat anti-mouse secondary antibody 
(1:200 in TBS with 1% BSA and 2% NGS, Vector Laboratories, Burlingame, CA, Catalog #BA-
9200) as applied for 30 minutes in a humidity chamber at room temperature. The slides were 
washed in TBS with BSA solution and incubated with Vectastain ABC solution (Vector 
Laboratories, Burlingame, CA, Catalog #PK-6000) for 30 minutes per manufacturer’s protocol. 
After the ABC solution, Immpact DAB Peroxidase Substrate Solution (Vector Laboratories, 
Burlingame, CA, Catalog #SK-4105) was applied for 7 minutes per manufacturer’s instructions. 
The reaction was stopped by running tap water for 5 minutes. The slides were taken back 
through the alcohol gradient to dehydrate the slices. Once dry the slides were mounted with 
cytoseal (Thermo Scientific, Wilmington, DE, Catalog #8310-4). A negative control was created 
for each slice by incubating with TBS with 1% BSA and 2% NGS and no primary antibody. 
Slides were then imaged with light microscopy.  
sPLA2 and DKK1 Immunohistochemistry  
 5µm sections of tissue were placed on a slide and incubated overnight at 37°C. Slices 
were then taken through a standard dewaxing and dehydration process using Citrisolve (Thermo 
Scientific, Wilmington, DE, Catalog# 22-143975) and an alcohol gradient. Antigen retrieval was 
performed by boiling the slides in 10mM sodium citrate (pH 6.0) for 20 minutes and leaving in 
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the hot sodium citrate for one hour. The slides were washed in phosphate buffered saline (PBS) 
for 10 minutes and blocked in 10% normal goat serum (NGS) in PBS with 1% bovine serum 
albumin (BSA) at room temperature for 2 hours. The slides were blotted dry and incubated in 
either primary anti-phospholipase A2 rabbit polyclonal antibody (1:200 in PBS with 1% BSA, 
Abcam, San Francisco, CA, ab23705) or primary anti-DKK1 rabbit polyclonal antibody (1:200 
in PBS with 1% BSA, Abcam, San Francisco, CA, ab93017) overnight at 4°C in a humidity 
chamber. The next day, slides were washed in PBS for 10 minutes and incubated at room 
temperature in a humidity chamber with 0.3% H2O2 in PBS for 15 minutes to suppress 
endogenous peroxidase activity and reduce background staining. The slides were then incubated 
with horseradish peroxidase conjugated goat polyclonal secondary antibody to rabbit IgG 
(1:5000 in PBS with 1% BSA, Abcam, San Francisco, CA, ab6721) for 1 hour in a humidity 
chamber at room temperature. The slides were rinsed in PBS three times for 5 minutes and 
Immpact DAB Peroxidase Substrate Solution (Vector Laboratories, Burlingame, CA, Catalog 
#SK-4105) was applied for 10 minutes per manufacturer’s instructions. To stop the color 
reaction the slides were rinsed in running water for 5 minutes. The slides were then taken back 
through the alcohol gradient for dehydration. Once dry the slides were mounted with cytoseal 
(Thermo Scientific, Wilmington, DE, Catalog #8310-4). A negative control was created for each 
slice by incubating with TBS with 1% BSA and 2% NGS and no primary antibody. Slides were 




 Previously, a microarray experiment performed on days 14, 16, and 18 was used to 
identify gene expression patterns in the endometrium of pregnant and non-pregnant mares 
(Bruemmer et al. 2010). The data were analyzed to uncover log 2-fold differences in gene 
expression with regard to day and pregnancy. Genes were considered significantly differential 
expressed with P<0.001 and a fold-change greater than 3. Table 3 lists the seven genes that had 
higher expression in endometrium from pregnant mares at each time point and Table 4 lists the 
three genes that had lower expression in endometrium from pregnant mares at each time points.  
qRT-PCR 
 qRT-PCR for day 12 endometrial samples from pregnant and non-pregnant mares 
revealed differential patterns of expression of  JAZF1, sPLA2, S100G, ESR1, SLC36A2, and 
DKK1, that were also consistent with the microarray results. Other genes, METTL7A, RALDH1, 
EIF2AK3, and ADM, expression levels according to qRT-PCR were not consistent with the 
microarray results for days 14, 16, and 18. Figure 2 shows the relative expression levels of each 







Table 3: Microarray Results for Days 14, 16, and 18 with Higher Expression in Endometrium from Pregnant Mares 
Gene 
Symbol 
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another zinc finger 
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4 Regulation of 
transcription, DNA 
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Table 3 Continued 
Gene 
Symbol 








DKK1 Dickkopf 1 homolog 1 Negative regulation of 


































Table 4: Microarray Results for Days 14, 16, and 18 with Lower Expression in Endometrium from Pregnant Mares 
Gene 
Symbol 
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Figure 2: Day 12 Endometrial mRNA qRT-PCR Results 
  
This figure demonstrates the higher and lower expression levels of each of the genes on 
day 12 endometrium from pregnant and non-pregnant mares. Expression levels are 
represented by the !Ct and error bars represent the standard error of the mean. One star 
denotes P<0.05 and two stars denotes P<0.01.  
 
 qRT-PCR analysis on day 14 endometrium from pregnant and non-pregnant mares 
revealed expression patterns of each of the genes that was also consistent with the prior 
microarray results. JAZF1 ,S100G, ESR1, SLC36A2, METTL7A, and EIF2AK3, showed 
differences in expression levels between endometrium from pregnant and non-pregnant mares. 
METTL7A and EIF2AK3 were up-regulated in the endometrium from pregnant mares on day 14. 































Figure 3: Day 14 Endometrial mRNA qRT-PCR Results 
 
This figure demonstrates the higher and lower expression levels of each of the genes on 
day 14 endometrium from pregnant and non-pregnant mares. The regulation in the 
pregnant endometrium is consistent with the microarray results Expression levels are 
represented by the !Ct and error bars represent the standard error of the mean. One star 
denotes P<0.05 and two stars denotes P<0.01.  
 
 On day 16, qRT-PCR in on endometrium from pregnant and non-pregnant mares 
revealed expression patterns consistent with the microarray results. ESR1, SLC36A2, EIF2AK3, 
and ADM were up or down regulated in the endometrium from pregnant mares. Figure 4 shows 





































Figure 4: Day 16 Endometrial mRNA qRT-PCR Results 
This figure demonstrates the higher and lower expression levels of each of the genes on 
day 16 endometrium from pregnant and non-pregnant mares. The regulation in the 
pregnant endometrium is consistent with the microarray results Expression levels are 
represented by the !Ct and error bars represent the standard error of the mean. One star 
denotes P<0.05.  
 
 Day 18 qRT-PCR results were also consistent with the microarray results for all genes. 
sPLA2 and RALDH1 were among the few significantly differentially expressed genes. ADM and 
JAZF1 were the only two genes not to show a significant higher or lower expression level in 
endometrium from pregnant mares. Figure 5 shows the relative expression of each of the genes 

































Figure 5: Day 18 Endometrial mRNA qRT-PCR Results 
This figure demonstrates the higher and lower expression levels of each of the genes on 
day 18 endometrium from pregnant and non-pregnant mares. The regulation in the 
pregnant endometrium is consistent with the microarray results Expression levels are 
represented by the !Ct and error bars represent the standard error of the mean. One star 
denotes P<0.05 and two stars denotes P<0.01.  
 
 Expression patterns were also analyzed for each gene across days 12, 14, 16, and 18 in 
endometrium from pregnant and non-pregnant mares. JAZF1 was not statistically different across 
the days. Figure 6A shows the expression pattern of JAZF1 across days and Figure 6B depicts 




































Figure 6: JAZF1 Endometrial mRNA Relative Expression Across Days 
This figure demonstrates the expression pattern of JAZF1 in endometrium from pregnant 
and non-pregnant mares. Panel A shows the comparison of the relative expression across 
days 12, 14, 16, and 18 post-ovulation, with significance being demonstrated with 
differing letters. Panel B demonstrates the expression of JAZF1 in endometrium from 
pregnant mares compared to endometrium from non-pregnant mares.  
 
sPLA2 across days 12, 14, 16, and 18, in endometrium from pregnant non-pregnant mares 
had expression differences. In non-pregnant mares there was no expression difference across 
days, but there was a difference in pregnant mares. Figure 7A shows the expression pattern of 
sPLA2 across days and Figure 7B depicts the relative expression of sPLA2 across days in 
endometrium from pregnant versus non-pregnant mares.  
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Figure 7: sPLA2 Endometrial mRNA Relative Expression Across Days 
 
This figure demonstrates the expression pattern of sPLA2 in endometrium from pregnant 
and non-pregnant mares. Panel A shows the comparison of the relative expression across 
days 12, 14, 16, and 18 post-ovulation, with significance being demonstrated with 
differing letters. Panel B demonstrates the expression of sPLA2 in endometrium from 
pregnant mares compared to endometrium from non-pregnant mares.  
 
S100G had a higher expression level on all days in endometrium from pregnant mares, 
but across days 12, 14, 16, and 18 there is no difference between pregnant and non-pregnant 
mares. Figure 8A shows the expression pattern of S100G across days and Figure 8B depicts the 




Figure 8: S100G Endometrial mRNA Relative Expression Across Days 
This figure demonstrates the expression pattern of S100G in endometrium from pregnant 
and non-pregnant mares. Panel A shows the comparison of the relative expression across 
days 12, 14, 16, and 18 post-ovulation, with significance being demonstrated with 
differing letters. Panel B demonstrates the expression of S100G in endometrium from 
pregnant mares compared to endometrium from non-pregnant mares.  
 
ESR1 was consistently expressed at higher levels in the endometrium from non-pregnant 
mares versus pregnant mares on each day. There was no difference across days for the non-
pregnant mares and for the pregnant mares, although a decline was observed in pregnant mares. 
Figure 9A shows the expression pattern of ESR1 across days and Figure 9B depicts the relative 
expression of ESR1 across days in endometrium from pregnant versus non-pregnant mares.  
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Figure 9: ESR1 Endometrial mRNA Relative Expression Across Days 
 
This figure demonstrates the expression pattern of ESR1 in endometrium from pregnant 
and non-pregnant mares. Panel A shows the comparison of the relative expression across 
days 12, 14, 16, and 18 post-ovulation, with significance being demonstrated with 
differing letters. Panel B demonstrates the expression of ESR1 in endometrium from 
pregnant mares compared to endometrium from non-pregnant mares.  
!
SLC36A2 was higher expressed in endometrium from pregnant mares versus non-
pregnant mares at all time points. Across the time points there was no differences in pregnant 
mares and no differences across days for non-pregnant mares. There was a difference observed 
between some time points between endometrium from pregnant and non-pregnant mares. Figure 
10A shows the expression pattern of SLC36A2 across days and Figure 10B depicts the relative 
expression of SLC36A2 across days in endometrium from pregnant versus non-pregnant mares.  
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Figure 10: SLC36A2 Endometrial mRNA Relative Expression Across Days 
 
This figure demonstrates the expression pattern of SLC36A2 in endometrium from 
pregnant and non-pregnant mares. Panel A shows the comparison of the relative 
expression across days 12, 14, 16, and 18 post-ovulation, with significance being 
demonstrated with differing letters. Panel B demonstrates the expression of SLC36A2 in 
endometrium from pregnant mares compared to endometrium from non-pregnant mares.  
 
METTL7A had a higher expression level in endometrium from a non-pregnant mare on 
day 12 post-ovulation, but on days 14, 16, and 18 post-ovulation had a higher expression level in 
endometrium from a pregnant mare. Across days 12-18 post-ovulation there was a significant 
decrease in METTL7A expression in endometrium from non-pregnant mares, while in pregnant 
mares the expression pattern did not change. Figure 11A shows the expression pattern of 
METTL7A across days and Figure 11B depicts the relative expression of METTL7A across days 
in endometrium from pregnant versus non-pregnant mares.  
! "#!
 
Figure 11: METTL7A Endometrial mRNA Relative Expression Across Days 
 
This figure demonstrates the expression pattern of METTL7A in endometrium from 
pregnant and non-pregnant mares. Panel A shows the comparison of the relative 
expression across days 12, 14, 16, and 18 post-ovulation, with significance being 
demonstrated with differing letters. Panel B demonstrates the expression of METTL7A in 
endometrium from pregnant mares compared to endometrium from non-pregnant mares.  
 
RALDH1 had a higher expression level in endometrium from pregnant mares on day 12 
post-ovulation, but then had a higher expression level in endometrium from non-pregnant mares 
on days 14-18 post-ovulation. When evaluated across days there was no difference observed in 
endometrial samples from both pregnant and non-pregnant mares. Figure 12A shows the 
expression pattern of RALDH1 across days and Figure 12B depicts the relative expression of 




Figure 12: RALDH1 Endometrial mRNA Relative Expression Across Days 
 
This figure demonstrates the expression pattern of RALDH1 in endometrium from 
pregnant and non-pregnant mares. Panel A shows the comparison of the relative 
expression across days 12, 14, 16, and 18 post-ovulation, with significance being 
demonstrated with differing letters. Panel B demonstrates the expression of RALDH1 in 
endometrium from pregnant mares compared to endometrium from non-pregnant mares.  
EIF2AK3 had a higher expression level in endometrium from non-pregnant mares on day 
12 post-ovulation, but had a higher expression level in endometrium from pregnant mares on 
days 14-18 post-ovulation. When evaluated across days there was a significant difference in 
endometrium from non-pregnant mares as the days progressed. In endometrium from pregnant 
mares there was no difference across days in EIF2AK3 expression levels. Figure 13A shows the 
expression pattern of EIF2AK3 across days and Figure 13B depicts the relative expression of 
EIF2AK3 across days in endometrium from pregnant versus non-pregnant mares.  
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Figure 13: EIF2AK3 Endometrial mRNA Relative Expression Across Days
 
This figure demonstrates the expression pattern of EIF2AK3 in endometrium from 
pregnant and non-pregnant mares. Panel A shows the comparison of the relative 
expression across days 12, 14, 16, and 18 post-ovulation, with significance being 
demonstrated with differing letters. Panel B demonstrates the expression of EIF2AK3 in 
endometrium from pregnant mares compared to endometrium from non-pregnant mares.  
 
DKK1 had a higher expression level in endometrium from pregnant mares on days 12-18 
post-ovulation. When evaluated across days there were differences between days in the 
endometrium from both pregnant and non-pregnant mares. Interestingly, DKK1 on day 12 post-
ovulation in endometrium from pregnant mares was expressed significantly higher than 
endometrium from day 18 post-ovulation non-pregnant mares. Figure 14A shows the expression 
pattern of DKK1 across days and Figure 14B depicts the relative expression of DKK1 across 
days in endometrium from pregnant versus non-pregnant mares.  
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Figure 14: DKK1 Endometrial mRNA Relative Expression Across Days 
 
This figure demonstrates the expression pattern of DKK1 in endometrium from pregnant 
and non-pregnant mares. Panel A shows the comparison of the relative expression across 
days 12, 14, 16, and 18 post-ovulation, with significance being demonstrated with 
differing letters. Panel B demonstrates the expression of DKK1 in endometrium from 
pregnant mares compared to endometrium from non-pregnant mares.  
 
ADM was significantly higher expressed in endometrium from non-pregnant mares on 
day 12 post-ovulation, but higher expressed in endometrium from pregnant mares on days 14-18 
post-ovulation. When evaluated across days there was no significant differences found. Figure 
15A shows the expression pattern of ADM across days and Figure 15B depicts the relative 
expression of ADM across days in endometrium from pregnant versus non-pregnant mares.  
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Figure 15: ADM Endometrial mRNA Relative Expression Across Days
 
This figure demonstrates the expression pattern of ADM in endometrium from pregnant 
and non-pregnant mares. Panel A shows the comparison of the relative expression across 
days 12, 14, 16, and 18 post-ovulation, with significance being demonstrated with 
differing letters. Panel B demonstrates the expression of ADM in endometrium from 
pregnant mares compared to endometrium from non-pregnant mares.  
 
Real-time PCR results for days 12, 14, 16, and 18 confirm the previously obtained 
expression patterns in endometrium from pregnant and non-pregnant mares, although not all 
genes at all time points showed higher or lower expression levels. Day 12 results were consistent 
with the later days for 6 of the genes, JAZF1, sPLA2, S100G, ESR1, SLC36A2, and DKK1, but 
METTL7A, RALDH1, EIF2AK3, and ADM levels showed an opposite expression pattern. These 




Table 5: Microarray and qRT-PCR Results Summarized 
 
This table summarizes the results from the microarray and qRT-PCR. One star denotes 
P<0.05 and two stars denotes P<0.01.  
 
Gene Microarray  
Day 14, 16, 
18 
PCR Day 12 
Pregnant vs. 
Non-Pregnant 
PCR Day 14 
Pregnant vs. 
Non-Pregnant 
PCR Day 16 
Pregnant vs. 
Non-Pregnant 
PCR Day 18 
Pregnant vs. 
Non-Pregnant 
JAZF1 HIGHER HIGHER HIGHER* HIGHER HIGHER 
sPLA2 LOWER LOWER LOWER LOWER LOWER** 
S100G HIGHER HIGHER HIGHER* HIGHER HIGHER** 
ESR1 LOWER LOWER** LOWER** LOWER* LOWER* 
SLC36A2 HIGHER HIGHER HIGHER** HIGHER* HIGHER** 
METTL7A HIGHER LOWER HIGHER* HIGHER HIGHER* 
RALDH1 LOWER HIGHER LOWER LOWER LOWER** 
EIF2AK3 HIGHER LOWER HIGHER** HIGHER HIGHER 
DKK1 HIGHER HIGHER* HIGHER HIGHER HIGHER* 
ADM HIGHER LOWER* HIGHER HIGHER* HIGHER 
 
Western Blots 
 Western Blot analysis was conducted to confirm the specificity of the antibodies to 
DKK1 or sPLA2 in equine endometrium because they were not designed with the equine peptide, 
but have been confirmed in various species. Endometrium from day 13  pregnant and non-
pregnant mares was utilized for this experiment. Figure 6 shows the western blot with the 
endometrial protein from pregnant and non-pregnant mares for sPLA2, which has a predicted 
size of 14 kDa, and Figure 7 shows the western blot with the endometrial protein from pregnant 
and non-pregnant mares for DKK1, which has a predicted size of 38 kDa.  
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Figure 16: Western Blot Analysis for sPLA2  
Western Blot analysis on day 13 endometrial protein in pregnant and non-pregnant 
endometrium confirmations that the rabbit polyclonal sPLA2 antibody is specific for 
sPLA2 in equine endometrium. sPLA2 is 14 kDa in size and is detected in pregnant and 
non-pregnant endometrium in the above figure.  
 
  
Figure 17: Western Blot Analysis for DKK1 
 
Western Blot analysis on day 13 endometrial protein in pregnant and non-pregnant 
endometrium confirmations that the rabbit polyclonal DKK1 antibody is specific for 
DKK1 in equine endometrium. DKK1 is 38 kDa in size and is detected in pregnant and 
non-pregnant endometrium in the above figure.  




sPLA2  - 14 kDa 
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Localization of sPLA2 and DKK1 was determined by immunohistochemistry. ESR1 was 
included as a positive control and in the endometrium from pregnant mares localized to the basal 
region of the glandular epithelium. Very little staining for ESR1 was found in the luminal 
glandular region and the endometrial epithelium. In the endometrium from non-pregnant mares, 
ESR1 localization was throughout the endometrium, and detected in the endometrial epithelium 
and throughout the glandular epithelium. This localization can be seen in Figure 8. 
 
Figure 18: ESR1 Localization in the Endometrium from Pregnant and Non-Pregnant 
Mares 
 
Immunohistochemistry on day 13 endometrium from pregnant and non-pregnant mares 
for ESR1 identifies the cellular location of this protein. The negative control for each 
tissue section is in the lower right region of each picture.  
 
 sPLA2 was localized to the endometrial epithelium and the glandular cells. This 
localization pattern did not vary between the endometrium from pregnant and non-pregnant 
endometrium on day 13. Figure 9 shows the localization of this protein. 
  Pregnant      Non-Pregnant 
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Figure 19: sPLA2 Localization in the Endometrium from Pregnant and Non-Pregnant 
Mares
 
Immunohistochemistry on day 13 endometrium from pregnant and non-pregnant mares 
for sPLA2 identifies the cellular location of this protein. The negative control for each 
tissue section is in the lower right region of each picture.  
 
 The localization of DKK1 endometrium from pregnant and non-pregnant mares was 
determined by immunohistochemistry on day 13 endometrium. In pregnant endometrium, DKK1 
is localized to the endometrial epithelium and in the glandular cells in the glandular region. In 
the endometrium from non-pregnant mares, very little staining is seen in both the endometrial 
epithelium and the glandular cells. The localization of this protein can be seen in Figure 10.  
Pregnant     Non-Pregnant 
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Figure 20: DKK1 Localization in the Endometrium from Pregnant and Non-Pregnant 
Mares 
 
Immunohistochemistry on day 13 endometrium from pregnant and non-pregnant mares 
for DKK1 reveals localization of this protein. The negative control for each tissue section 
is in the lower right region of each picture.  
   
  Pregnant     Non-Pregnant 
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Discussion 
 This experiment was performed to confirm and extend a previously performed equine 
specific microarray analysis on days 14, 16, and 18 post-ovulation in endometrium of pregnant 
and non-pregnant mares (Bruemmer et al. 2010). qRT-PCR was performed on days 12, 14, 16, 
and 18 to determine the relative expression level of JAZF1, sPLA2, S100G, ESR1, SLC36A2, 
METTL7A, RALDH1, EIF2AK3, DKK1, and ADM. Interestingly, six out of the ten genes were 
regulated in a similar manner on day 12 as they were on days 14, 16, and 18, but 4 genes 
switched relative expression levels in samples from pregnant versus non-pregnant mares between 
days 12 and 14 post-ovulation. qRT-PCR confirmed the results of the microarray across days 14, 
16, and 18. 
 On day 12 post-ovulation, JAZF1, sPLA2, S100G, ESR1, SLC36A2, and DKK1 were 
differentially expressed the same (higher or lower expression in endometrium from pregnant 
mares) as in days 14, 16, and 18. By day 12 post-ovulation, ESR1 had a significantly lower 
expression level in endometrium from pregnant mares. This corresponds to previous literature 
stating that ESR1 decreases during mid-estrus (Watson et al. 1992) and is down-regulated in 
early pregnancy due to the presence of progesterone (Spencer and Bazer 1995). Gene ontology 
for ESR1 revealed that is involved in uterus development and steroid hormone receptor activity. 
Immunohistochemistry for ESR1 on day 13 also corresponded with previous literature about its 
localization (Hartt et al. 2005). This experiment showed that in endometrium from pregnant 
mares ESR1 is localized in the lower stroma and glandular epithelium, but in endometrium from 
non-pregnant mares it is localized to the luminal and glandular epithelium.  
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On day 12 post-ovulation, DKK1 was also significantly higher expressed in endometrium 
from pregnant mares. Gene ontology of DKK1 revealed that it is involved in signal transducing 
activity, cell morphogenesis and is located in the extracellular region. DKK1 is a Wnt-signaling 
antagonist in the endometrium during pregnancy (Kawano and Kypta 2003) and may play an 
active role in preventing differentiation of the endometrium during early pregnancy. It has also 
been found to inhibit the attachment of the embryo to the endometrium (Liu et al. 2010). In early 
pregnancy preventing attachment is critical in order for the embryo to continue to be mobile 
throughout the entire uterine lumen, signaling maternal recognition of pregnancy. DKK1 is also 
up-regulated by high progesterone levels in the circulation (Atli et al. 2011).  
Immunohistochemistry revealed that DKK1 in endometrium from pregnant mares is located in 
the luminal epithelium and glandular cells, but very little localization of this protein was seen in 
these areas in endometrium from pregnant mares. This may indicate how DKK1 prevents 
attachment of the embryo to the endometrium during early pregnancy.  
 By day 14 post-ovulation, qRT-PCR analysis of all of the genes confirmed the microarray 
results in their expression levels in endometrium from pregnant mares. ESR1 continued to be 
significantly lower expressed on this day. Interestingly, EIF2AK3, and METTL7A both switch 
from having lower expression in endometrium from pregnant mares on day 12 post-ovulation to 
significantly higher expression on day 14 post-ovulation. Both of these genes are involved in 
gene transcription and modifications. EIF2AK3 spans the endoplasmic reticular (ER) membrane 
and is a major stress sensor in the ER (Li et al. 2003). When under stress, EIF2AK3 initiates the 
unfolded protein response so the cell can react to the stressor (Rutkowski and Kaufman 2004). 
This stress response may be triggered by the mobile conceptus in the uterine lumen. METTL7A 
is a methyltransferase that may be involved in the modification of specific genes and proteins. 
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Gene ontology identifies that METTL7A is involved in metabolic processes and transferase 
activities. Little research has been done to evaluate its role in the reproductive cycle.  
S100G and SLC36A2 are significantly higher expressed on day 14 post-ovulation in 
endometrium from pregnant mares. Both genes are involved in nutrient transport from the 
endometrium to the conceptus. S100G encodes for calbindin-D9k (CaBP9k), which is a calcium 
binding protein. S100G is involved in calcium and vitamin D binding. It is regulated by 
progesterone levels, so as progesterone increases S100G expression increases (Hoffmann et al. 
2009b). It is involved in providing the conceptus with necessary nutrients and a decrease in 
CaBP9k results in insufficient nutrients reaching the conceptus and conceptus death (Hoffmann 
et al. 2009b). The up-regulation of S100G may be critical in order for the conceptus to survive 
through early pregnancy prior to attachment. SLC36A2 is an H+ coupled amino acid transport 
system (Edwards et al. 2011). Gene ontology indicates that it is involved in ion and amino acid 
transport across the plasma membrane. It is thought to also be necessary for conceptus survival 
by providing the conceptus with the necessary amino acids during early pregnancy prior to 
attachment. Previous research identified SLC36A2 also as being up-regulated in day 13.5 
pregnant equine endometrium compared to endometrium from a non-pregnant mare (Klein et al. 
2010). RALDH1 also switches from being higher expressed on day 12 post-ovulation in 
endometrium from non-pregnant mares to lower expression on day 14 and JAZF1 is significantly 
higher expressed on day 14 post-ovulation in endometrium from pregnant mares. RALDH1 is 
involved in the retinol metabolic process and retinal dehydrogenase activity. Gene ontology of 
JAZF1 indicates that it is involved in the regulation of transcription by negative regulation of 
transcription from RNA polymerase II promoter. JAZF1 is a tumor suppressor that is found in 
the endometrium (Li et al. 2007). Mutations in this gene are implicated with endometrial stromal 
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tumors surrounding the endometrial glands under the surface epithelium (Li et al. 2007). JAZF1 
may be critical during the time of maternal recognition in order to support the endometrium 
during this time of many endometrial changes that will be occurring. 
 On day 16 post-ovulation, the genes all followed the same trend of expression as they did 
on day 14. Only ESR1, SLC36A2, EIF2AK3, and ADM had significantly different expression 
levels between endometrium of pregnant and non-pregnant endometrium on day 16. Day 16 also 
corresponds to the day of fixation of the embryo. At this point maternal recognition of pregnancy 
has occurred, so endometrial gene expression should be directed towards maintaining a 
successful pregnancy. Gene ontology of ADM indicates it is a positive regulater of angiogenesis 
and involved in the progesterone biosynthetic process. ADM is a vasodilator that causes an 
increase in uterine blood flow in the sheep (Cameron et al. 2002). It is also thought to regulate 
fetal and maternal blood pressure throughout pregnancy (Macri et al. 1996). In contrast to these 
results, ADM levels were increased when progesterone was declining and estrogen was 
increasing in rodents and humans (Cameron et al. 2002; Maybin et al. 2011). Data from this 
experiment suggest the opposite regulation is occurring in equine endometrium. More research 
needs to be done to determine the function of ADM in equine endometrium.  
 On day 18 post-ovulation, multiple genes became significantly differentially expressed. 
These genes included sPLA2, S100G, ESR1, SLC36A2, METTL7A, RALDH1, EIF2AK3, and 
DKK1. Each of these genes may play a critical role in maintaining the endometrium, allowing it 
to support a viable pregnancy. Day 18 post-ovulation is the first day that sPLA2 becomes 
significantly lower expressed in endometrium from pregnant mares. Gene ontology reveals that 
sPLA2 in involved in the phospholipid metabolic process, phospholipase A1 activity, and lipid 
catabolic processes. sPLA2 is involved in the synthesis of prostaglandin F2α (PGF) by releasing 
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arachadonic acid, the precursor to PGF, from the phospholipid bilayer (Needleman et al. 1986). 
Maximal sPLA2 expression is observed during maximal PGF synthesis and in the horse 
corresponds with the increased capacity to synthesize PGF in response to oxytocin stimulation 
(Sharp et al. 1997). The expression of sPLA2 negatively correlates with progesterone levels 
indicating that progesterone is a key regulator of sPLA2 expression (Ababneh et al. 2011). It has 
also been found bound to equine embryonic capsules, increasing in response to PGF (Hayes et al. 
2008). This may contribute to the breakdown of embryonic capsules resulting in early embryonic 
loss (Hayes et al. 2008). These results indicate that sPLA2 may play a critical role in PGF 
synthesis so it must be closely regulated during and after maternal recognition of pregnancy. On 
day 13 post-ovulation, sPLA2 was also identified to be located in the luminal epithelium and the 
glandular epithelium in the endometrium from pregnant and non-pregnant mares.  
RALDH1 also became significantly lower expressed on day 18 post-ovulation in 
endometrium from pregnant mares. It is a key regulator in retinoic acid synthesis (Duester et al. 
2003). Excess or deficiency of retinoic acid can result in abortion or embryonic malfunction 
(Mohan et al. 2001). In rodents excess retinoic acid can also induce blastocyst apoptosis (Huang 
et al. 2003). In rodents and humans RALDH1 is regulated by estrogen (Bucco et al. 1997; Deng 
et al. 2003). It has also been found to play a role in blastocyst-endometrium interaction (Duester 
et al. 2003). Due to the negative effects that excess retinoic acid may have on the blastocyst, 
RALDH1 expression must be closely regulated during and after maternal recognition of 
pregnancy.  
 Each of the ten genes may have a critical role in maternal recognition of pregnancy in the 
mare. These results indicate that some of the genes become increasingly more expressed in 
endometrium from pregnant mares as the number of days post-ovulation increases. The higher or 
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lower expression of these genes may lead to the identification of the signal for maternal 
recognition of pregnancy in the mare by identifying what is causing the expression of these 
genes.   
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CHAPTER III: DISCUSSION 
 The results from this experiment confirm and extend the results from a previously 
performed microarray experiment on days 14, 16, and 18 post-ovulation in endometrium from 
pregnant and non-pregnant mares. The results from day 12 post-ovulation for the ten previously 
identified genes, JAZF1, sPLA2, S100G, ESR1, SLC36A2, METTL7A, RALDH1, EIF2AK3, 
DKK1, and ADM, revealed that some of the genes were expressed in the same manner across 
days 12, 14, 16, and 18 post-ovulation and some genes that were expressed in the opposite 
manner and then switched by day 14 post-ovulation. Each of the previously identified genes may 
play a key role in maternal recognition of pregnancy in the mare due to their roles in regulation 
of transcription, nutrition transport, metabolic processes, biosynthetic processes, regulation of 
translation, angiogenesis, cell morphogenesis, and regulation of apoptosis.  
Juxtaposed with another zinc finger protein 1-like (JAZF1) 
Until recently not much information was known about the function of JAZF1. JAZF1 is 
present in many different tissues throughout the body but is found in highest levels in adipose 
and testicular tissue and moderate levels in the colon, placenta, prostate, and ovary (Nakajima et 
al. 2004). Recently, JAZF1 was found to be identical to TAK1-interacting protein 27 (TIP27). 
JAZF1 represses TGF-beta activated kinase 1 (TAK1) mediated transactivation and more 
specifically DR1-dependent transcriptional activation by TAK1, but the direct effect of this 
repression remains unknown (Nakajima et al. 2004).    
JAZF1 mutations have also been implicated in endometrial stromal tumors. These tumors 
occur in the mesenchymal tissue under the surface epithelium and surrounding the endometrial 
glands that are formed by invaginations of the surface epithelium (Li et al. 2007). In these tumors 
! 55!
JAZF1 is down regulated and instead the fusion of JAZF1-JJAZF1 (JAZF1-SUZ12) is noted in 
abundance. This fusion is seen only in endometrial stromal tumors and not normal endometrium 
(Koontz et al. 2001). The unmutated version of JAZF1 is thought to be a tumor suppressor (Li et 
al. 2007). JAZF1 has also been shown to be a transcriptional repressor of a gene that causes 
growth retardation in mice and height variation in humans (Johansson et al. 2009). Most recently, 
JAZF1 was found to show a potential role in glucose metabolism. Overexpression of JAZF1 
results in an increase in GLUT1, a glucose transporter (Li et al. 2011). JAZF1 is a novel gene 
whose complete functions and roles remain unknown. It has been found to have an effect on 
tumor suppression, glucose metabolism, and growth. Interestingly it is also found to be present in 
endometrium and when fused to JJAZF1 seems to play a role in endometrial stromal tumors 
showing its role in the regulation of transcription. 
 In this experiment, JAZF1 was higher expressed in endometrium from pregnant mares on 
all days (days 12-18 post-ovulation). This may be due to the role that JAZF1 may play in 
endometrial remodeling for pregnancy. It also acts as a tumor suppressor, which may be critical 
during early pregnancy to support the endometrium while it is undergoing functional changes.  
Secretory Phospholipase A2 (sPLA2) 
 Secretory phospholipase A2 (sPLA2) is a member of the phospholipase A2 enzyme 
family that is involved in the biosynthesis of prostaglandin F2α (PGF). sPLA2 binds to the 
anionic phospholipid bilayer and cleaves the phospholipid releasing it from the membrane. 
(Beers et al. 2003; Birts et al. 2008; Hayes et al. 2008). The phospholipid that is released from 
the lipid bilayer is arachadonic acid, the precursor to PGF. Once released, cystolic phospholipase 
A2 (cPLA2) mobilizes the arachadonic acid that is converted to prostaglandin H2 (PGH) and 
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eventually becomes PGF (Needleman et al. 1986). The PLA2 family are the rate limiting 
enzymes in the biosynthesis of prostaglandins (Ababneh et al. 2011). Maximal PLA2 activity has 
been found to correlate to the period of maximal PGF secretion in luteolysis, suggesting that 
PLA2 may have a direct effect on luteolysis. It also corresponds with the increased capacity to 
synthesize PGF in response to oxytocin stimulation (Sharp et al. 1997).  
Interestingly, a negative correlation between PLA2 expression levels and progesterone 
concentrations was described, inferring the control progesterone may have control over PLA2 
expression levels (Ababneh et al. 2011). This relationship was confirmed by progesterone 
supplementation to ovariectomized mares resulting in a decrease in the PLA2 family enzymes 
(Ababneh and Troedsson 2013). Throughout the estrous cycle, expression levels of the PLA2 
family vary in horses. There are high levels of expression during estrus, but they decline after 
ovulation. In the same study results showed that on day 15 expression levels of cPLA2 were 
similar between pregnant mares and non-pregnant mares that had not undergone functional 
luteolysis, indicating that cPLA2 specifically does not vary throughout the cycle (Ababneh et al. 
2011). This implies that sPLA2 may be the member of the PLA2 family that is varying based 
upon pregnancy status and progesterone concentration.  
 sPLA2 is also present bound to equine embryonic capsules. The amount bound to the 
capsule increases substantially in response to PGF (Hayes et al. 2008). The yolk sac walls of 
these embryos were also evaluated to determine the level of sPLA2, and they contained very low 
expression levels. This implies that bound sPLA2 originates in the endometrium (Hayes et al. 
2012). It is proposed that binding of sPLA2 to the capsule in the response to PGF contributes to 
the removal and breakdown of the capsule and the conceptus, possibly resulting in early 
embryonic loss (Hayes et al. 2008). While the function of sPLA2 is well understood, such as its 
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involvement in hormone biosynthesis, its role and regulation during maternal recognition of 
pregnancy remains to be understood.  
 sPLA2 is lower expressed in endometrium from pregnant mares on all days in the this 
experiment with it being significantly lower expressed on day 18 post-ovulation. Since it plays a 
key role in PGF synthesis, it needs to be down regulated in endometrium from pregnant mares in 
order to decrease PGF synthesis in the endometrial cells. Localization of sPLA2 protein also 
revealed it is concentrated in the endometrial epithelium and the glandular cells. The location did 
not change between pregnant and non-pregnant endometrium. This may indicate that some 
sPLA2 is constitutively present in order to aid in the PGF pathway when properly signaled to be 
activated.  
S100 calcium binding protein G (S100G) 
 S100 calcium binding protein G (S100G) is the gene that encodes for calbindin-D9k 
(CaBP9k), which is a calcium binding protein. In general, S100G is involved in calcium and 
vitamin D binding. CaBP9k has been evaluated in the endometrium in many different species, 
but the regulation of expression levels varies among species (Inpanbutr et al. 1994). In the 
pregnant rat uterus CaBP9k is localized in the glandular epithelium, myometrium, and 
endometrial stroma (Bruns et al. 1988). Expression levels vary throughout the estrous cycle but 
are higher in estrogen dominated phases and lower in progesterone dominated phases (Inpanbutr 
et al. 1994). This implies that in the rat uterus, CaBP9k is controlled by estrogen and/or inhibited 
by progesterone. CaBP9k expression in the rat also coincides with myometrial contractility 
(Mathieu et al. 1989). It is controlled in an opposite manner in other species. In humans, there 
are higher expression levels in progesterone dominated periods, such as the luteal phase, with 
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expression levels of CaBP9k peaking during the menstrual phase. Elevated CaBP9k levels have 
also been found during pregnancy and maintained until labor (Inpanbutr et al. 1994). The bovine 
uterus regulates CaBP9k expression in the same manner as humans. It is more present in the 
luteal phase than the follicular phase, indicating it is also regulated by progesterone. The 
localization is also specialized in cattle. CaBP9k is localized to the glandular epithelium, with 
lower expression levels seen closer to the uterine lumen (Inpanbutr et al. 1994).  
 In the mare, CaBP9k expression levels are controlled by progesterone in the same manner 
as the human and the cow. As serum progesterone concentration increases, there is an increase in 
CaBP9k (Hoffmann et al. 2009a). In equine endometrium CaBP9k is localized to the glandular 
epithelium with maximal staining and maximal expression observed during early to mid-estrus 
(Hoffmann et al. 2009a). Since CaBP9k is a calcium binding protein there has been speculation 
that expression levels also have an effect on the nutritional supply to the conceptus. Recent 
studies have shown that decreased levels of CaBP9k lead to an insufficient nutrient supply 
reaching the conceptus, ultimately leading to conceptus death (Hoffmann et al. 2009a). This 
information suggests that CaBP9k expression is important for embryo survival in the equine 
endometrium and that progesterone levels are necessary for the regulation of CaBP9k.  
 In this experiment S100G is higher expressed in endometrium from pregnant mares 
across all days. This confirms that it is regulated by progesterone because across all the time 
points progesterone is the dominating hormone. If its role is to supply nutrition to the conceptus, 
higher expression in endometrium from pregnant mares is critical for the survival of the 
conceptus.   
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Estrogen Receptor 1 (ESR1) 
 Estrogen receptor 1 (ESR1), previously known as estrogen receptor α (ERα), is a steroid 
hormone receptor that has been well characterized in many species throughout pregnancy and the 
estrous cycle. It is involved in the regulation of apoptotic processes, uterus development, and 
steroid hormone activity, indicated by its gene ontology. In a few species, such as pigs and cows, 
ESR1 remains present in early pregnancy (Robinson et al. 1999; Knapczyk-Stwora et al. 2011). 
Although ESR1 remains present in the cow, the mRNA levels of ESR1 decrease significantly 
from day 0-18 of pregnancy (Fürst et al. 2012). In sheep, ESR1 is down-regulated during early 
pregnancy, due to the presence of progesterone. In sheep, estrogen up-regulates steroid hormone 
receptors and progesterone down regulates steroid hormone receptors (Spencer and Bazer 1995). 
The regulation of ESR1 behaves in the same manner in primates. Progesterone down-regulates 
ESR1 in the secretory phase compared to high expression levels in the late-proliferative phase 
(Okulicz et al. 1993).  
 Research in equine endometrium for expression of ESR1 has shown different results. 
ESR1 is localized to the luminal and glandular epithelium during estrus, but in diestrus and early 
pregnancy it is not present in the luminal epithelium, only in the lower stroma and glandular 
epithelium (Hartt et al. 2005). ESR1 concentration is highest during estrus and early diestrus, but 
lowest during mid-estrus (Watson et al. 1992). Regulation of the receptors is the same in the 
equine endometrium as it is in ovine and primate endometrium, which is progesterone down-
regulates steroid hormone receptors and estrogen up-regulates steroid hormone receptors (Hartt 
et al. 2005). In early pregnancy the conceptus derived estrogens also down-regulate ESR1 
receptors in the endometrium (Klein et al. 2010). Interestingly fetal membranes also show ESR1 
expression (Wilsher et al. 2011). While the localization and presence of ESR1 has been shown in 
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multiple studies, varying results have been shown regarding mRNA levels in the endometrium. 
One study shows that ESR1 mRNA decreases during days 11-20 of pregnancy, while another 
study shows there is no difference in mRNA levels between days 8-15 of pregnancy (McDowell 
et al. 1999; Hartt et al. 2005).While localization and expression of ESR1 is well characterized in 
horses, expression levels and how the expression is controlled is still yet to be defined.  
 On days 12, 14, 16, and 18 post-ovulation, ESR1 was lower expressed in endometrium 
from pregnant mares. This also corresponds with previous results for ESR1 in endometrium 
being decreased during days 11-20 of pregnancy (McDowell et al. 1999). Localization of ESR1 
also corresponded with previous data. In the endometrium from pregnant mares it is localized to 
the lower stroma and glandular region, but not the endometrial epithelium. In non-pregnant 
endometrium it was localized throughout the epithelium and glandular region.   
Solute carrier family 36 (proton/amino acid symporter), member 2 (SLC36A2) 
 Solute carrier family 36 (proton/amino acid symporter), member 2 (SLC36A2) is a 
member of the SLC36 family of transporter-related genes, consisting of four members (Edwards 
et al. 2011). It is also known as phosphate acetyl transferase, PAT2. Not much is known 
regarding SLC36A2 or PAT2, except that it is involved in the transport of amino and fatty acids 
(Foltz et al. 2004). Gene ontology also reveals that it is involved in glycine trnsmembrane 
transporter activity. It is a H+ coupled amino acid transport system that has been identified in a 
multiple locations throughout the body (Edwards et al. 2011). It is localized to myelinating 
neuronal Schwann cells, suggesting a role in amino acid supply in differentiation of those cells 
(Bermingham et al. 2002). SLC36A2 has also been identified to be involved in amino acid 
movement in neuronal tissue (Rubio-Aliaga et al. 2004). Recently it has been shown to be 
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specifically involved in glycine, proline, and hydroxyproline reabsorption. When a mutation is 
present in this gene it has major effects on the reabsorption of these amino acids (Bröer et al. 
2008).  
 Very little research has been done with the involvement of SLC36A2/PAT2 in the 
reproductive system. Recently SLC36A2 has been shown to be present in equine endometrium. It 
was up-regulated on day 13.5 of pregnancy compared to endometrium from non-pregnant mares 
on day 13.5 (Klein et al. 2010). It is though to be involved in the appropriate delivery of nutrients 
to the conceptus before attachment occurs. SLC36A2/PAT2 is a transporter that has been 
identified, but needs to be evaluated more to determine its involvement with the conceptus and 
pregnancy.  
 In this experiment, SLC36A2 is higher expressed in endometrium from pregnant mares 
across all time points. These results also confirm a previous study showing the up-regulation of 
SLC36A2 in endometrium from pregnant mares on day 13.5 (Klein et al. 2010). SLC36A2 is 
important in amino acid and proton transport. This is necessary in order to provide the conceptus 
with the necessary nutrients for survival.   
Methyltransferase-like protein 7A-like (METTL7A) 
 Methyltransferase-like protein 7A-like (METTL7A) is a member of the super family of 
methyltransferases. A methyl transferase removes the methyl group from a donor and puts it on 
an acceptor. Little research has been done on the function of METTL7A, but it has been 
identified in many different tissues throughout the body. During pregnancy, METTL7A is found 
in the chorion of human placentas (Nhan-Chang et al. 2010). It has also been identified in 
podocytes that were excreted in urine from the kidney (Prunotto et al. 2013). Most notably it has 
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been identified to be in lipid droplets and to be a part of lipid metabolism (Brasaemle and Wolins 
2012). No research has been done to date on METTL7A in the endometrium and it’s involvement 
in pregnancy in humans or horses.  
 In this experiment METTL7A is lower expressed on day 12 post-ovulation in 
endometrium from pregnant mares, but then has higher expression on days 14-18 post-ovulation. 
As a methyltransferase it is involved in the regulation of genes. This higher expression in 
endometrium from pregnant mares on day 14 may be a result of maternal recognition of 
pregnancy and the need to modify additional genes in order to prevent luteolysis.  
Retinaldehyde dehydrogenase 1-like (RALDH1) 
 Retinaldehyde dehydrogenase 1-like (RALDH1) is also known as ALDH1A1. It is a key 
regulator in retinoic acid synthesis, which becomes Vitamin A (Duester et al. 2003). The main 
function in of RALDH1 in retinoic acid synthesis is to catalyze retinaldehyde in to retinoic acid. 
RALDH2 and CYP26A1 are also critical enzymes in retinoic acid synthesis (Deng et al. 2003). 
Retinoic acid and vitamin A have a role in pregnancy and embryo balance. There is a very 
delicate line between deficiency and excess of vitamin A. Both extremes can lead to abortion or 
embryonic malfunction (Mohan et al. 2001). Research has been done looking at retinoic acid and 
RALDH1 in the mouse. Retinoic acid was found to suppress decidualization, differentiation, and 
development of the blastocyst. It can also induce blastocyst cell apoptosis (Huang et al. 2003). 
From this the authors concluded that excess retinoic acid can decrease the viability of 
mammalian blastocysts and can regulate cell death (Huang et al. 2003).  
 RALDH1 has also been identified in high concentrations in the murine oocyte, blastocyst, 
and hatched blastocyst. This suggests that RALDH1 and retinoic acid plays a role in blastocyst-
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endometrium interaction (Duester et al. 2003). The regulation of RALDH1 has been an active 
area of research. Expression levels of RALDH1 fluctuate throughout the estrous cycle. When 
rodents were administered pregnant mare serum gonadotropin (PMSG), which increases estrogen 
levels, retinoic acid production was increased (Bucco et al. 1997). This suggested that RALDH1 
expression is regulated by estrogen. In humans RALDH1, RALDH2, and CYP26A1 expression 
levels are also regulated by estrogen (Deng et al. 2003). While research has been done looking at 
humans and rodents, little research regarding RALDH1 expression and its role in equine 
pregnancy has been performed.   
 RALDH1 in this experiment is higher expressed on day 12 post-ovulation in endometrium 
from pregnant mares, but then has a lower expression on days 14-18. This expression change 
may be due to the endometrium recognizing the presence of a mobile conceptus. This down 
regulation is critical because of RALDH1’s role in retinoic acid and vitamin A synthesis. Too 
little or too much vitamin A and retinoic acid can result in embryonic death (Mohan et al. 2001). 
The lower expression also becomes more significantly different by day 18 post-ovulation leading 
to the necessity to regulate this gene.  
Eukaryotic translation initiation factor 2-alpha kinase 3 (EIF2AK3) 
 Eukaryotic translation initiation factor 2-aplha kinase 3 (EIF2AK3) is also known as 
pancreatic endoplasmic reticulum eIF2α kinase (PERK) (Li et al. 2003). EIF2AK3 spans the 
endoplasmic reticulum (ER) membrane and is one of the major sensors in the ER that activates 
the unfolded protein response when the cell is under stress so that it can react to the stressor (Li 
et al. 2003; Rutkowski and Kaufman 2004). EIF2AK3 is also a major regulator of IGF-1 
dependent neonatal growth (Li et al. 2003). Recently EIF2AK3 has been linked to Wolcott-
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Rallison syndrome. Deficiency of EIF2AK3 in humans leads to permanent neonatal diabetes 
associated with Wolcott-Rallison syndrome (e et al. 2004). A mutation in the EIF2AK3 gene also 
leads to Wolcott-Rallison syndrome (Delépine et al. 2000). EIF2AK3 is also involved in the 
regulation of translation, protein kinase activity, and nucleotide binding. While the role EIF2AK3 
plays in causing Wolcott-Rallison disease is well understood, research has not been done on the 
role it may play in the endometrium and/or during pregnancy.  
 In this experiment, EIF2AK3 is lower expressed on day 12 post-ovulation in 
endometrium from pregnant mares, but is then higher expressed for days 14-18. On day 14 post-
ovulation there is a dramatic, significant switch to higher expression in endometrium from 
pregnant mares. EIF2AK3 is a major regulator of stress sensory in cells, so the mobile conceptus 
may be creating a stress response in the endometrial cells. The mobility of the conceptus is 
critical for maternal recognition of pregnancy and initiating the stress response in cells may be 
part of the maternal recognition mechanism.  
Dickkopf 1 homolog (DKK1) 
 Dickkopf 1 homolog (DKK1) has been described to be a Wnt signaling antagonist during 
pregnancy (Kawano and Kypta 2003). Wnt signaling is crucial to estrogen mediated uterine 
growth, but has also been described to have many other functions (Hou et al. 2004). These 
functions include cell proliferation, differentiation and polarity, epithelial-mesenchymal 
communication, and embryogenesis (Wodarz and Nusse 1998). DKK1 is also unique in that it’s 
function, regulation, and presence is conserved across many species. In rodents it is expressed in 
preimplantation embryos and the stromal cells of the uterus (Li et al. 2008). It is secreted by the 
decidual cells and induces trophoblast cell invasion, playing an essential role in embryo 
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implantation. This was further confirmed by injecting antisense oligonucleotides of DKK1 into 
the uterine horn on day 3 of pregnant murine endometrium. This resulted in inhibition of embryo 
implantation (Li et al. 2008). In humans DKK1 has been found to inhibit the attachment of the 
embryo in a dose-dependent manner (Liu et al. 2010). Interestingly it is up regulated in human 
endometrium during the midsecretory phase, corresponding to the implantation period, of the 
menstrual cycle. This also corresponds to when circulating progesterone levels are at their 
highest (Tulac et al. 2003). These results were confirmed in four other human studies showing 
that DKK1 is up-regulated in this phase (Bauersachs and Wolf 2012). Further research revealed 
that in human endometrium DKK1 is activated by progesterone in the endometrial stromal cells 
(Tulac et al. 2006). In contrast, DKK1 is also up-regulated in human endometrium when estrogen 
and progesterone serum concentration levels are high, as seen in humans being over stimulated 
for in vitro fertilization procedures (Liu et al. 2010).  
 Research in other species has confirmed that DKK1 regulation is conserved across 
species. In sheep, DKK1 expression levels are dependent upon progesterone. It is hypothesized 
that its role is to inhibit Wnt signaling pathways in the trophoblast giant binucleate cells in the 
endometrial stroma and prevent their migration into the stroma (Hayashi et al. 2007). In bovine 
endometrium DKK1 is up-regulated during the luteal phase and at day 18 of pregnancy 
(Bauersachs and Wolf 2012). This confirmed that in cattle DKK1 is also regulated by 
progesterone. Recently, DKK1 was evaluated in equine endometrium. Studies have shown that it 
is also up-regulated during periods of high progesterone (Atli et al. 2011). While DKK1 has been 
studied extensively in human endometrium, its role in other species is not as well defined. It is 
known that it inhibits the Wnt signaling pathway and prevents attachment, but the down stream 
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effects of this inhibition still remain unknown. Gene ontology revealed that DKK1 is also 
involved in cell morphogenesis in differentiation, protein binding, and signal transducing activity.  
 In this experiment DKK1 was higher expressed across all time points in endometrium 
from pregnant mares. This corresponds to previous research stating that DKK1 expression is 
regulated by progesterone in the endometrium. When determining the localization pattern of 
DKK1, there were differences between endometrium from pregnant and non-pregnant mares. In 
the endometrium from pregnant mares it was localized to the glandular epithelium and the 
glandular cells. In the endometrium from non-pregnant mares, DKK1 staining is less present in 
the endometrial epithelium. This may be due to the function of DKK1 in the endometrium. The 
equine conceptus is mobile until day 16 but does not attach to the endometrium until day 36. 
DKK1 has been found to inhibit attachment in other species (Liu et al. 2010), so in the mare it 
may be serving the same function, leading to its up regulation on days 12, 14, 16, and 18.  
Adrenomedullin (ADM) 
 Adrenomedullin (ADM) is a versatile peptide that has been found performing multiple 
functions throughout the body. Its functions include a vasodilator, bronchodilator, regulator of 
hormone secretion, neurotransmitter, antimicrobial agent, and controller of renal function. It has 
also been implicated in tumor biology, such as tumors of pulmonary and neural lineage (Zhao et 
al. 1998; Julián et al. 2005). Due to all of its functions it is located in many different tissue types 
in the body. It plays a large role in the female reproductive tract in tissue remodeling, but its 
regulation is not well known. It is found in the endometrium of many non-pregnant animals 
including rat, human, and sheep (Zhao et al. 1998; Cameron et al. 2002). In the sheep uterus it is 
a potent vasodilator causing increased uterine blood flow (Cameron et al. 2002). It has also been 
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found in amniotic fluid and the epithelium of human amnion, and the chorioallantoic membrane 
of the chicken (Macri et al. 1996; Zhao et al. 1998). Due to its location throughout the 
reproductive system it implies that ADM plays a vital role in pregnancy and embryogenesis. It is 
also thought to regulate fetal and maternal blood pressure throughout pregnancy (Macri et al. 
1996). 
 In the murine uterus it is located in the stroma of the endometrium and the myometrium 
(Cameron et al. 2002). ADM levels have been directly correlated to estradiol concentrations in 
serum, with the highest levels of both being in proestrus and estrus. It is proposed that it’s role is 
to inhibit muscular tone in the myometrium and suppress uterine contractility (Cameron et al. 
2002). ADM levels are also raised throughout pregnancy, supporting it’s role in suppressing 
contractility (Cameron et al. 2002). Due to pregnancy causing ADM levels to be high it is 
thought that the endometrium produces the ADM (Upton et al. 1997). Interestingly, when ADM 
is given as a treatment in late gestation to a mice with preeclampsia, which causes hypertension 
and pup mortality, the hypertension is reversed and there is reduced pup mortality (Makino et al. 
1999).  
 In the human, ADM is also localized to the stroma and is also an endothelial cell growth 
factor (Zhao et al. 1998). It shares homology with calcitonin gene related peptide and is thought 
to be able to bind to the calcitonin receptor (Zhao et al. 1998). In humans, ADM is thought to be 
involved in endometrial repair. It has the highest expression level in the menstrual phase and 
protein levels are highest in the menstrual and early proliferative phases (Maybin et al. 2011). In 
humans, two pathways have been identified to regulate ADM. The first pathway is a HIF-1-
mediated hypoxic induction and the other is a HIF-1 independent PGF pathway. Both of these 
pathways are triggered by the decline in progesterone (Maybin et al. 2011). Overall ADM has 
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many functions, but it plays an important role in the estrous cycle and pregnancy by increasing 
vasodilation and blood flow to the endometrium.  
 In this experiment, ADM had lower expression on day 12 post-ovulation in endometrium 
from pregnant mares, but then higher expression on days 14, 16, and 18. This expression change 
after day 12 may be due to recognition of a mobile conceptus in the uterus. Interestingly this 
regulation does not correspond with human and mouse data, where ADM is regulated by the 
decrease in progesterone. The up regulation of ADM in the endometrium during early pregnancy 
may be critical in order to increase the blood flow to the endometrium.  
Pathway Analysis 
 Ingenuity systems was used to evaluate the pathway of the ten genes of interest. The top 
molecular and cellular functions were lipid metabolism and small molecule biochemistry. Five of 
the molecules are directly involved in tissue morphology and the other five are involved in organ 
development. The major upstream regulator of the molecules is progesterone, which is the main 
hormone during pregnancy. The main genes regulated by progesterone are ADM, RALDH1, 
DKK1, ESR1, and S100G. Figure 21 shows the network analysis of JAZF1, sPLA2, S100G, ESR1, 
SLC36A2, METTL7A, RALDH1, EIF2AK3, DKK1, and ADM, their locations within the cell, and 
their connections to the other genes. 
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Figure 21:Pathway Analysis of Candidate Genes 
 
Pathway analysis from Ingenuity Systems for nine of the ten candidate genes. METTL7A is not included in this image but it is 
located in the endoplasmic reticulum and the plasma membrane.
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Conclusion 
 This is the first experiment to confirm and expand upon the results of an equine specific 
microarray previously performed (Bruemmer et al. 2010). Each of the ten genes, JAZF1, sPLA2, 
S100G, ESR1, SLC36A2, METTL7A, RALDH1, EIF2AK3, DKK1, and ADM, identified by the 
microarray may be critical in maternal recognition of pregnancy and in attenuating the 
production of PGF, ultimately preventing luteolysis of the corpus luteum and sustaining a viable 
pregnancy. These genes need to be continued to be evaluated for protein levels varying across 
time points throughout early pregnancy. The exact mode of regulation of these genes also needs 
to be identified, whether it is the mobile conceptus contacting the endometrium or secretions 
from the conceptus during maternal recognition of pregnancy. The identification of the 
mechanism of maternal recognition of pregnancy in the mare is critical in furthering the equine 
reproduction industry and preventing early embryonic loss.  
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APPENDIX I: RIPA LYSIS BUFFER RECIPES 
 
 
RIPA Lysis Buffer 
 150mL of ddH2O 
 0.484g Tris (pH 8.0) 
 1.6 NaCl 
 20mL Glycerol 
 2mL NP-40 (Nonidet P-40) 
 0.2g SDS (sodium dodecyl sulfate) 
 1.0g Deoxychlorate 
 0.117g EDTA (ehtylenediamine tetraacetic acid) 
 Lower to pH 8.0 with HCl 
 Bring up to 200mL with ddH2O 
 
Proteinase Inhibitor Cocktail- PIC (10X) 
 15mL of ddH2O 
 0.138g Sodium Vanadate 
 0.117g Benzanidine 
 
Phenylmethanesulfonyl Fluoride- PMSF (20mM) 
 3.48mg PMSF (phenylmethanesulfonyl fluoride) 
 1mL EtOH  
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APPENDIX II: PCR PRIMERS 
 
 
Table 6: Designed PCR Primers for Identified Genes 
 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
JAZF1 GCTCTCGCTGACCTTGTCCA AAGGAAGAGGAGGGGGTGATG 
SPLA2 CAGGGGCATTTGCTGGATTT CATCCTTGGGGGATCCTTTG 
S100G TGAGCTTGAAAAAGTCTCCTGAAG AAGCGGGGAGTTCATTCTGG 
ESR1 AGAACAGCCCCGTCTTGTCC ACCCATCATGGAAGCCTCGT 
SLC36A2 CCAGACCTTGGTTCACCTGCT GCCAATTGCCAGCAAACTGA 
METTL7A TGTATTGACCCCAACCCCAAC GCCACCTGGTGCATGTTCTC 
RALDH1 CCACCAAGGCCAATGTTGTG GGGTCAGCGGATTTCCAAGA 
EIF2AK3 CGTGCGCAGACTTTTCCATC CGTCATTCGAGCCACTGTCA 
DKK1 CCTTGGATGGGTACTCCAGAAGA GGACCAGAAGTGTCTGGCACA 
ADM GCTGGTTCCCGTAACCCTCA TTCCCTCTTCCCACGACTGA 
GAPDH CACCCAGAAGACCGTGGATG AGGGATGACCTTGCCCACAG 
TUBA1B ACGTGGTTCCCAAAGATGTC CACAGTGGGAGGCTGGTAAT 
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APPENDIX III: 12% SDS-PAGE POLYACRYLAMIDE GEL PREPARATION 
 
Running Gel 
 0.9mL H2O 
 2.0mL 1M Tris pH 8.8 
 2.0mL 30% Acrylamide Solution 37.5:1 (Bio-Rad, Hercules, CA, Catalog #161-0158) 
 50µL 10% SDS 
 2.5µL TEMED (Bio-Rad, Hercules, CA, Catalog #161-0800) 
 25µL 10% APS 
 
Stacking Gel 
 2.8mL H2O 
 0.5mL 1M Tris pH 6.8 
 0.66mL 30% Acrylamide Solution 37.5:1 (Bio-Rad, Hercules, CA, Catalog #161-0158) 
 40µL 10% SDS 
 10µL TEMED (Bio-Rad, Hercules, CA, Catalog #161-0800) 
 50µL 10% APS 
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